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                                 ABSTRACT OF DISSERTATION 
                                                  
The contribution of two related BBP-binding GYF proteins, 
Smy2 and Syh1, to cellular RNA abundance 
and genome stability 
 
    Nuclear precursor of mature messenger RNA (pre-mRNA) splicing is one of the most 
highly regulated processes in eukaryotic organisms. In addition to its role in the removal 
of constitutive or alternative introns present in the pre-mRNA, splicing is also highly 
integrated into other layers of gene expression. This study investigates the potential role 
of the nuclear branchpoint binding protein (BBP) outside of the pre-mRNA splicing cycle. 
More specifically, we were interested in the biological relevance of its association with 
two cytoplasmic proteins Smy2 and Syh1. Smy2 and Syh1 belong to the GYF family of 
poly-proline binding proteins, and their roles in cell biology have not been well 
elucidated.  
   Here we report that Smy2 and Syh1 act redundantly in: (i) limiting pre-mRNA 
accumulation when yeast cultures reach high cell density, potentially through promoting 
pre-mRNA decay in the cytoplasm; (ii) restricting Ty1 retrotransposition, apparently by 
limiting the Ty1 transcript abundance; (iii) limiting the accumulation of BBP-associated 
yet intronless TDA1 mRNA. With the presence of UACUAAC motif and BBP association 
as common features of these Smy2/Syh1 sensitive substrates, we tested if BBP interaction 
is required for Smy2/Syh1 function in RNA metabolism. Interestingly, we found that 
deletion of BBP C-terminal region, which reduces or abolishes its association with Smy2, 
does not lead to similar phenotypes as observed in smy2∆ syh1∆ deletion mutant cells. In 
addition, mutagenesis of the TACTAAC BBP-binding site within the TDA1 coding region 
does not seem to affect TDA1 mRNA abundance or its sensitivity to the smy2∆ syh1∆ 
deletions. Therefore, we concluded that while the two BBP-binding proteins Smy2 and 
Syh1 impact the levels of certain cellular RNAs, this phenomenon is not strictly 
dependent upon BBP-Smy2 interaction and may be independent of BBP contribution.  A 
model is proposed for Smy2 and Syh1 function in RNA metabolism based on our 
observations and interactions between these proteins with other factors implicated in 
RNA stability or translation.  
Key Words: BBP, Smy2/Syh1, pre-mRNA splicing, RNA decay, retrotransposition 
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Chapter 1  Introduction 
    Since the acceptance of Mendel’s genetic inheritance laws in the early 20th century, 
scientists have sought to understand the molecular mechanisms by which genetic 
information is inherited and what leads to the differences in organismal phenotypes 
displayed between individuals. The discovery of DNA as the carrier of genetic 
information (Avery et al. 1944) and the illustration of DNA structure (Watson and Crick 
1953) marked the beginning of our understanding of genetics at the molecular level. The 
“central dogma of  molecular biology” (Crick 1970) illustrates the flow of genetic 
information from its original form as DNA to the intermediate messenger as RNA and to 
the translated protein product. The pathway has been enriched in detail since its 
establishment in 1970, but the general rules still hold true. The removal of introns from 
most eukaryotic transcription units was found later as an additional and regulated step in 
gene expression (reviewed in Kornblitt et al., 2013). Mis-regulated splicing is linked to 
many developmental defects and human diseases (Cooper et al. 2009). In addition, recent 
studies have shown crosstalk between the factors guiding the splicing reaction and those 
governing other cellular processes, including RNA transcription, RNA export, mRNA 
translation and decay (Maniatis and Reed 2002). As such, the study of splicing is best 
viewed from both specific and holistic perspectives.   
 In this chapter, I will start with a brief introduction of spliceosome assembly and the 
two-step splicing reaction (1.1), focusing mostly on the baker’s yeast (Saccharomyces 
cerevisiae) system. Where appropriate, I will provide guidance on the studies 
demonstrating the interaction of splicing with other cellular processes (1.2). More 
information will be provided on the splicing factor of my interest- the branchpoint 
binding protein (BBP), which functions in early spliceosome assembly, promotes pre-
mRNA nuclear retention and potentially functions outside of the splicing cycle (1.3-1.6). 
The focus of this study is in BBP interaction with two cytoplasmic GYF proteins, Smy2 
and Syh1, of which the cellular roles remain largely unknown but are implicated in the 
transport, translation or turnover of mRNA (1.7). A hypothesis focusing on possible BBP 
-Smy2/Syh1 interaction in the regulation of mRNA abundance is proposed and tested 
(1.8).    
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1.1 The removal of introns from intron-containing pre-mRNA is an essential step in 
gene expression 
     Most eukaryotic genes contain one or more introns, which need to be properly 
removed to form translatable mRNA. The process of intron removal is called pre-mRNA 
splicing, which is catalyzed by a multi-subunit enzyme called spliceosome. The 
spliceosome is a RNA-protein complex consisting of five small nuclear ribonucleoprotein 
particles (snRNPs), each of which contains one of five conserved small nuclear RNAs 
(U1, U2, U4, U5 and U6 snRNAs) with associated proteins and a set of non-snRNP 
spliceosomal proteins. There have been more than 90 spliceosome-associated proteins 
identified in yeast and 170 in humans (Fabrizio et al. 2009 and references within). 
Despite of the greater complexity of the human spliceosome, homologs of nearly all the 
yeast spliceosomal proteins can be identified in humans, indicating an evolutionary 
conservation of the core splicing machinery between yeast and human.  
     Spliceosome assembly requires the recognition of consensus splice-site sequences in 
the intron to define the exon-intron boundaries. The 5’ splice site (consensus: G-
GUAUGU in yeast and G-GUAAGU in mice and human, with the dash between the two 
Gs representing the exon-intron junction) is necessary for the recruitment of U1 small 
nuclear ribonucleoprotein particle (snRNP), in part through base-pairing with 5’ U1 
snRNA (Rosbash and Seraphin, 1991).  The 3’ intron region is more complex: the 
conserved dinucleotide 3’ AG with an adjacent poly-pyrimidines (PY)-rich tract (not 
prominent in budding yeast) and a highly conserved branchpoint sequence (BPS) further 
upstream. In yeast, the 3’ splice site and PY-tract are less important for early spliceosome 
assembly and function mainly in the second step of splicing, since pre-mRNA without 
these feature undergo the first step of splicing efficiently (Rymond and Rosbash, 1985). 
     During the splicing cycle, the spliceosome assembles in an ordered and stepwise 
pattern, which then catalyzes the splicing reaction (Fig. 1.1). First, U1 snRNP recognizes 
the 5’ splice site through base-pairing between 5’ splice site and U1 snRNA to form the 
commitment complex (Rosbash and Seraphin, 1991).  Next, the U2 snRNP is recruited 
through protein-based associations and base-paring between the U2 snRNA and a highly 
conserved branchpoint sequence of the pre-mRNA. The addition of U2 snRNP is also 
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mediated by its interaction with U1 snRNP components (Ares, 1986; Parker et al., 1987). 
This pre-spliceosome is transformed into the complete spliceosome with the addition of 
the U4/U6.U5 tri-snRNP particle. The tri-snRNA contains U4 snRNA which is found 
extensively base paired through two helical regions with the U6 snRNA.  The U5 snRNP 
is associated with U4/U6 snRNPs through protein-protein interactions (Moore et al., 1993; 
Staley and Guthrie, 1998). It was reported that U5 snRNP also interacts with the 3’ region 
(conserved dinucleotide AG with an adjacent poly-pyrimidine (PY)-rich tract which is 
not prominent in budding yeast) (Chiara et al., 1997). In addition, there is compelling 
evidence indicating that U5 snRNP directly interacts with exon sequences flanking the 5’ 
and 3’ splice sites and tethers the two exons together after the first catalytic step in the 
splicing reaction (reviewed in Newman, 1997).    
Once the five snRNPs are present, the spliceosome undergoes major structural 
transformations to become catalytically active. During this process, the U1 snRNA-5’ 
splice site interaction is disrupted, and replaced by a U6 snRNA-5’ base-pairing 
interaction. The base-pairing between U4-U6 snRNAs is lost and the U4 snRNP is 
released from the spliceosome. The U2/U5/U6 snRNP-containing spliceosome then 
catalyzes the two trans-esterification reactions: in the first reaction, the branchpoint 
adenosine attacks the phosphate group of 5’ splice site to form a free exon 1 and a lariat 
intermediate; in the second reaction, the free hydroxyl group of exon 1 attacks the 
phosphate group of 3’ splice site and results in a mature mRNA and a lariat intron (Moore 
et al., 1993; Staley and Guthrie, 1998). Generally, the processed mRNA is then exported 
into cytoplasm for translation, the lariat intron is debranched and degraded, and the 
spliceosome is disassembled and recycled for next round of splicing. Eight DExD/H-box 
ATPase proteins with high structural similarity promote the spliceosome cycle by 
disrupting specific RNA-RNA and RNA-protein interactions at distinctive steps in 
spliceosome assembly and disassembly reactions (Staley and Guthrie, 1998).  
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Figure 1.1. A simplified model of the spliceosome assembly and splicing in S. 
cerevisiae. The two boxes represent exons, and the linear line in between represents the 
intron with conserved 5’ splice site (GU), branchpoint sequence (*: UACUAAC) and 3’ 
splice site (AG) marked. The green circles represent the snRNPs, which undergo ordered 
and step-wise assembly and disassembly. With mature spliceosome, the two exons are 
ligated into the mRNA and the intron is removed for degradation. BBP and Mud2 are two 
non-snRNP splicing factors acting early in spliceosome assembly to help commit the 
unprocessed pre-mRNA to the splicing pathway.  
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1.2 Integration of splicing with other steps in gene expression 
     Eukaryotic gene expression starts with transcription of a gene, followed by pre-mRNA 
processing and export of the mature mRNA into cytoplasm where it is either translated or 
degraded. Much is known about that the molecular mechanisms of splicing from studies 
conducted in vivo and in vitro systems (reviewed in Staley and Guthrie, 1998). It has 
become increasingly clear in recent years that the splicing process is highly integrated 
with other steps in the gene expression pathway. 
     The study of crosstalk between transcription and splicing has been a hot topic for 
scientific investigation over the past 15-20 years (Reviewed in Kornblihtt et al., 2004; 
Han et al., 2011; Braunschweig et al., 2013; Darnell, 2013). It is now a consensus that 
most constitutive and alternative splicing is co-transcriptional (e.g., in yeast, Tardiff et al., 
2006). This conclusion is based on many lines of evidence, including, (i) spliceosome 
assembly and intron removal proceed prior to the completion of RNAPII transcription 
(Görnemann et al., 2005; Singh and Padgett, 2009); (ii) Spliced mRNA products are 
physically associated with chromatin (Bauren and Wieslander, 1994; Pandya-Jones and 
Black, 2009); (iii) Splicing factors are capable of  affecting the transcription efficiency of 
certain genes if not all (Fong and Zhou, 2001) and transcription elongation rates affect the 
splice site selections (Reviewed in Kornblihtt et al., 2004). The great extent of co-
transcriptional splicing was further supported by several genome-wide analyses of co-
transcriptional and post-transcriptional RNA processing in yeast and mammalian cell 
lines (reviewed in Braunschweig et al., 2013). These studies also suggest that exceptions 
to co-transcriptional splicing may be enriched in genes encoding critical developmental 
regulators and genes associated with stress response.   
     The carboxyl terminal domain (CTD) of the largest RNAPII subunit is believed 
critical for coupling transcription with pre-mRNA splicing. The CTD consists of repeated 
amino acid sequences (consensus: Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), with 26 in 
yeast and 52 in vertebrates.  The CTD is reversibly modified through the phosphorylation 
on Tyr1-Ser2-Thr4-Ser5-Ser7 residues which modulate the CTD contribution to 
transcription, 5’ capping, pre-mRNA splicing and 3’ polyadenylation (Hsin and Manley, 
2012). A truncated CTD sequence leads to defects in transcription and subsequent pre-
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mRNA processing steps (McCracken et al., 1997). The investigation of CTD-associated 
protein partners has revealed several splicing factors and other pre-mRNA processing-
related proteins. The list of protein candidates (Prp40 and Spt5 in budding yeast) that 
potentially couple transcription to splicing was presented in the Kornblihtt et al., 2004 
review, but evidence of direct linkage for most factors is still missing. The cap-binding 
complex (CBC) was also identified as necessary but not sufficient, for co-transcriptional 
spliceosome assembly (Görnemann et al., 2005).  
      Accumulating evidence also links chromatin structure to splicing regulation. Although 
pre-mRNA sequence and splicing-related proteins associated with the intron and exon 
features largely define the exon-intron boundaries, chromatin features may affect the 
splicing outcomes as well (reviewed in Braunschweig et al., 2013; Schwartz and Ast, 
2010 and references within). For instance, it has been shown that there is relatively higher 
nucleosome occupancy in the exonic regions compared with neighboring intron 
sequences (Andersson et al., 2009). In addition, global examinations of histone 
modification profiles have revealed differential distribution of certain histone 
modifications (e.g., trimethylation of lysine 36 on histone H3-H3K36me3) between 
exons and introns (Andersson et al., 2009; Huff et al., 2010).  It is not clear yet how the 
chromatin structures affect the splicing machinery. However, there is evidence that the 
recruitment of splicing factors to the nascent transcript is facilitated by their interactions 
with chromatin (Sims et al., 2007; Tolstorukov et al., 2012). It is also proposed that 
chromatin structure affects splicing by altering the rate of RNAPII elongation 
(Braunschweig et al., 2013 and references within). A recent study in budding yeast 
suggests that the SR-like protein Rpl3, which is required for efficient co-transcriptional 
splicing, interacts with chromatin modification factors and might mediate the crosstalk 
(Moehle et al., 2012). This is consistent with the versatile functions of the serine/arginine 
(SR)-rich protein family in regulation of gene expression from transcription to RNA 
processing to translation in mammals (Zhong et al., 2009).  
     As mentioned above, there is also evidence connecting the process of splicing to pre-
mRNA 3’ processing, nuclear export and RNA stability. For example, the splicing factors 
U2AF65, which binds to the poly-pyrimidine tract at the 3’ intronic region, also influences 
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polyadenylation site choices through interaction with the 3’ processing factor CF 1(m) 
(Millevoi et al., 2006; reviewed in Di Giammartino et al., 2011). U1 snRNP, in addition 
to its role in pre-mRNA splicing, prevents the pre-mRNA from premature 3’-end 
processing at cryptic sites and promote accurate cleavage and polyadenylation of mRNAs 
(Gunderson et al., 1998; Kaida et al., 2010; Berg et al., 2012). The pre-mRNA splicing is 
also proof-read by several nuclear or cytoplasmic RNA degradation pathways through 
removing unspliced or mis-spliced pre-mRNA (reviewed in Parker, 2012). Multiple 
studies indicate that unspliced pre-mRNAs that are exported into the cytoplasm are 
degraded by the nonsense mediated decay (NMD) machinery (Rebbapragada and Lykke-
Andersen, 2009; Sayani et al. 2008).  These transcripts generally contain premature 
termination codons (PTC), and NMD is believed to help prevent the production of 
potentially toxic peptides derived from aberrant mRNAs. In addition, there are examples 
where alternative splicing is regulated to specifically introduce a PTC into the spliced 
product and thereby down-regulate gene expression by directing the RNA to the NMD 
pathway (Pan et al., 2006; Lareau et al., 2008). 
 
1.3 The splicing factor BBP belongs to the STAR protein family of proteins whose 
members are implicated in gene regulation from RNA synthesis through decay. 
     The branchpoint binding protein (BBP) is the yeast homolog of the mammalian 
splicing factor 1 protein (ySF1). It was named for its ability to bind specifically to the 
pre-mRNA intronic branchpoint sequence (BPS) UACUAAC, independent of any other 
splicing factors (Berglund et al., 1998). BBP belongs to the STAR/GSG protein family, 
which are highly conserved across the species (Rymond, 2010). STAR stands for the 
Signal Transduction and Activation of RNA, whereas GSG refers to the three original 
members GRP33, Sam68, and GLD-1. STAR proteins are characterized by a single maxi-
KH RNA binding domain flanked by an N-terminal QUA1 domain and a C-terminal 
QUA2 domain (Fig1.2. and Vernet and Artzt, 1997). STAR proteins usually function as 
homodimers through their QUA1 domains, which is proposed to enhance the RNA 
binding (Chen and Richard, 1998; Meyer et al., 2010). QUA2 is also proposed to 
participate in RNA binding (Liu et al., 2001). Interestingly, yeast BBP and mammalian 
SF1 contain a hetero-dimerization (instead of a homo-dimerization) domain required for 
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interaction with another splicing factor Mud2 and U2AF65 binding, respectively. This 
heterodimerization is believed to increase BBP/SF1 binding strength to RNA (Berglund 
et al., 1998).  The C-terminal region is not conserved in primary sequences among STAR 
proteins, but is often regulated by alternative splicing and the encoded polypeptides are 
decorated by post-translational modifications. The C-terminal regions often contain the 
proline or tyrosine-rich regions, or SH2/SH3/WW domain interacting sites, suggesting a 
role relevant to signal transduction (Vernet and Artzt, 1997).  
     Previous studies have shown that STAR proteins undergo multiple post-translational 
modifications and participate in almost all aspects of RNA metabolism, including pre-
mRNA synthesis and processing, mRNA export and localization, and mRNA translation 
or degradation. Sam68 is the most versatile and well-studied STAR protein, which was 
first identified as a Src-associated substrate during mitosis of 68kDa (Taylor and 
Shalloway, 1994; Fumagalli et al., 1994) and tyrosine phosphorylated by the Src-like 
kinase Fyn as well (Wang et al., 1995). The mammalian Sam68 is generally nuclear-
localized, but shuttles into cytoplasm during certain developmental stages or in response 
to stimuli (Henao-Mejia and He, 2009; Paronetto et al., 2006). In the nucleus, Sam68 
modulates the transcription of its target genes through interactions with transcription 
factors or regulators (Hong et al., 2002). The Sette lab (Paronetto et al., 2007) also 
showed that tyrosine phosphorylation of Sam68 by the Src-like kinase Fyn promotes pro-
apoptotic Bcl-x(s) splicing versus anti-apoptotic Bcl-x(l). This observation is consistent 
with induction of apoptosis when Sam68 is up-regulated (Paronetto et al., 2007). In 
addition, Sam68 enhances the exon5 inclusion of CDC44 pre-mRNA. This occurs in 
response to Sam68 serine/threonine phosphorylation, instead of tyrosine phosphorylation 
within the C-terminal signal transduction domain by the extracellular signal-regulated 
kinase (ERK) through activation of Ras that is stimulated, for instance, in response to 
phorbol ester treatment (Matters et al. 2002). These pioneering studies suggest that STAR 
proteins can regulate the splicing of cellular mRNA targets in response to extracellular 
stimuli. In the cytoplasm, Sam68 interacts with translation initiation factor eIF4F to 
enhance the translation of a subset of mRNAs required for germ cell differentiation 
(Patonetto et al., 2009). Interestingly, Sam68 also enhances the nuclear export and 
translation of viral RNAs (Coyle et al., 2003; Modem et al., 2005). In contrast, to date the 
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STAR proteins BBP and SF1 have largely been studied in relation to pre-mRNA splicing 
and in the nuclear retention of unprocessed pre-mRNA (Rutz et al., 2000; Wang et al., 
2008; Zhang et al., 2013).  
 
1.4 The ySF1/BBP was first identified as an early spliceosome component.  
    The yeast BBP encoding gene, MSL5, was first identified in a synthetic lethal screen 
with a mud2 mutant allele encoding only the conserved C-terminal RNA-binding domain 
(RBD) of splicing factor Mud2 (Abovich and Rosbash, 1997). The mud2 mutant was 
previously shown to have a synthetic lethal (SL) interaction with a mutant but viable U1 
RNA construct, indicating an early role in splicing and consistent with the structural 
similarity between Mud2 and the mammalian U2-snRNP associated factor 65 (U2AF65), 
a protein identified by Michael Green’s lab as critical for the initial stages of pre-mRNA 
splicing (Zamore et al., 1992). Follow-up studies in yeast showed that Mud2 is an early 
splicing complex component, but not a stable U1 snRNP protein, and revealed its 
association with pre-mRNA is dependent on a proper pre-mRNA branchpoint sequence. 
Genetic interaction of MUD2 with U1 RNA and U2 snRNP components suggested a role 
for Mud2 in mediating interactions between 5’ss and 3’ss regions during the initial U1-
dependent, ATP-dependent commitment complex stage of spliceosome assembly 
(Abovich et al., 1994; Wang et al., 2008).   
Further studies revealed that BBP is also a component of the commitment complex, 
and has a strong interaction with Mud2, and with the U1 snRNP proteins Prp39 and 
Prp40 (Abovich and Rosbash, 1997; Wang et al., 2008). Therefore, BBP was proposed to 
work with Mud2, bridging the 5’ and 3’ intron recognition. The BBP-Mud2 interaction is 
conserved in mammalian cells as SF1- U2AF65 association (Abovich and Rosbash, 1997). 
The SF1- U2AF65 interaction is enhanced by serine phosphorylation of SF1 by the 
protein kinase KIS on an SPSP motif between the U2AF65 and RNA-binding domains 
(Manceau et al., 2006). A separate report showed Ser20 phosphorylation of SF1 by the 
cGMP-dependent protein kinase-I (PKG-I), which, however, inhibits its association with 
U2AF65 (Wang et al., 1999). These observations indicate the modulation of SF1 activity 
and thus splicing efficiency by signaling pathways.   
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A.  
 
 
 
 
 
B.  
 
 
 
 
 
 
                                                                                            (Adapted from Artzt and Wu, 2010) 
Figure 1.2.  BBP belongs to the STAR protein family.  (A) The phylogenetic tree of the 
STAR proteins across the species. (B) Structural demonstration of select STAR proteins. 
QUA1 homo-dimerization domain, KH/QUA2 RNA-binding domain, and C-terminal 
signaling transduction domain are marked. BBP and SF1 possess a hetero-dimerization 
domain at the N-terminal instead, with the hetero-dimerization partner marked.  
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The initial characterization of yeast BBP/Mud2 function in BPS definition and 
commitment complex assembly was provided by Berglund et al. 1997 who showed that 
BBP interacts with the highly conserved yeast intron BPS UACUAAC (branchpoint A 
underlined) specifically and directly through its RNA-binding KH domain. This 
observation was further supported by an in vitro systematic evolution of ligands by 
exponential enrichment (SELEX) study with recombinant S. cerevisiae BBP and a panel 
of synthetic RNAs (Guth and Valcárcel, 2000; Garrey et al., 2006). Studies on 
mammalian SF1 suggests that this protein recognizes a related but more degenerate BPS 
(YNCURAY: Y-pyrimidine, R-purine, N-any nucleotide) with lower affinity (Moore et al., 
1993; Arning et al., 1996). The association of U2 snRNP to BPS requires the removal of 
BBP/Mud2 heterodimer, which is mediated by the DEAD-box ATPase Sub2 (Kistler and 
Guthrie, 2001; Wang et al., 2008). Interestingly, yeast Sub2 and its higher organism 
counterparts have been shown to also function in co-transcriptional mRNP biogenesis and 
mRNA export (Strasser and Hurt, 2001). Although BBP and Mud2 are also co-
transcriptionally recruited to the transcribed chromatin (Gornemann et al., 2005), it is 
unknown whether they are components of mRNPs and if either protein assists in the 
nuclear export of mRNAs. The study from mammalian cells indicates that U2AF65 
associates with subsets of spliced mRNAs and is proposed to modulate efficient transcript 
elongation (Huh et al., 2003; Ujavari and Luse, 2004; Gama-Carvalho et al., 2006). 
 
1.5 BBP participates in the nuclear retention of unprocessed pre-mRNA, and is 
important for cellular pre-mRNA splicing and essential for yeast viability. 
     BBP exists as a stable hetero-dimer in vivo with Mud2 through its N-terminal hetero-
dimerization domain (Wang et.al, 2008). In mammals but not yeast, a third protein, 
U2AF35, stably associates with U2AF65 and aids in 3’ splice site recognition (Wu et al., 
1999). Deletion of the first 56 amino acids of BBP (bbp∆56) weakens Mud2 association 
enough to prevent co-purification of the two proteins from yeast (Wang et.al, 2008). Loss 
of Mud2 or the inhibition of its association with BBP causes modest splicing defects in 
vivo. While the loss of BBP activity can inhibits splicing in vivo (Rutz and Seraphin, 
2000; Wang et.al, 2008), in vitro, most bbp temperature sensitive (ts) mutants show 
efficient splicing under all conditions (Rutz and Seraphin, 2000). Indeed, depletion 
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of >99% of BBP from extracts does not affect general pre-mRNA splicing (Rutz and 
Seraphin, 2000). While this most likely represents truly BBP-independent splicing, it is 
possible trace amounts of BBP remain after depletion and are sufficient for in vitro 
splicing. 
Pre-mRNA is retained in the nucleus for splicing and subsequently exported into the 
cytoplasm for translation. Several splicing factors (Bud13, Pml1, Snu17, Pml39 and 
Mlp1), plus an intact 5’ splice site and branchpoint site have been shown required for pre-
mRNA nuclear retention (Legrain and Rosbash, 1989; Dziembowski et al., 2004; Galy et 
al., 2004; Palancade et al., 2005). BBP and Mud2 play a role in pre-mRNA nuclear 
retention as well, as increased amount of unprocessed pre-mRNA has been reported in the 
cytoplasm in the bbp and mud2∆ mutants (Rutz and Seraphin, 2000; Wang et.al, 2008). 
Pre-mRNA generally contains pre-mature stop codons in the intron sequence rendering 
the cytoplasmic pre-mRNA substrates for nonsense mediated decay (NMD), a well 
conserved pathway for the removal of RNAs containing pre-mature translational 
termination codons (Sayani et al., 2008; Kawashima et al., 2009). Consistent with this 
idea, certain bbp mutations combined with a knockout mutation in the NMD pathway 
(i.e., upf1∆) are growth-impaired or synthetically lethal. Tellingly, the severity of this 
genetic interaction correlates with the extent of nuclear pre-mRNA export in the bbp 
mutants (Rutz and Seraphin, 2000).  
 
1.6 BBP is also associated with intronless mRNA and two cytoplasmic proteins, 
Smy2 and Syh1. 
Recently, Pat Brown’s group presented a large study in which many RNA binding 
proteins were purified from yeast and the RNAs associated with each identified. This 
group found that BBP purified from yeast is associated with many intronless mRNA 
(presumably cytoplasmic) in addition to the expected intron-containing pre-mRNA 
(Hogan et al., 2008). It was noted that many of the intronless mRNAs purified with BBP 
contain the UACUUAC consensus sequence (listed in Table 1.1), consistent with the high 
degree of site-specific binding of this protein. The study of mammalian BBP/SF1 binding 
substrates in vivo indicates a preferred intron binding, and sites mapped to exon regions 
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(Corioni et al., 2011). The mammalian Mud2 homolog, U2AF65, also associates with 
nascent transcripts from some intronless genes (Ujvári and Luse, 2004). It is unknown 
what effects of BBP and potentially Mud2 have on the associated intronless mRNAs, 
although in the case of Drosophila homolog of U2AF65, the presence of this protein on 
the intronless mRNA is proposed to enhance mRNA export into the cytoplasm and 
potentially has roles in other aspects of gene expression (Blanchette et al., 2004). 
     BBP is a nuclear protein (Huh et al., 2003), consistent with its function in splicing. 
Curiously, while the steady-state levels of a GFP-BBP derivative appear to be exclusively 
nuclear, BBP interacts with at least two cytoplasmic GYF proteins Smy2 and Syh1 
through the C-terminal proline-rich domain (Kofler et al., 2005; Georgiev et al., 2007; 
Wang et al., 2008; Ash et al., 2010). These interactions have been shown using the yeast 
two-hybrid system and in direct protein-protein binding studies. The stoichiometry of 
BBP binding with these two proteins is unknown. Likewise, while Sym2 and Syh1 might 
be expected to compete for BBP binding, the presence of at least six binding sites in BBP 
raises the possibility that both proteins might simultaneously bind BBP. Since BBP is 
nuclear-enriched and Smy2 & Syh1 cytoplasmic, one of these protein types must shuttle 
between the nucleus and cytoplasm for BBP to bind either Smy2 or Syh1.  BBP is a good 
candidate for shuttling as the mammalian homolog has been shown to shuttle (Corioni et 
al., 2011). Together these observations raise the possibility that BBP and maybe Mud2 
have a cytoplasmic function, outside of their role in the spliceosome cycle. It is not clear 
yet what function BBP might have in the cytoplasm or the biological relevance of the 
BBP interaction with Smy2 or Syh1. However, given what is known about the functions 
of other STAR proteins and the genetic and biochemical associations of Smy2 & Syh1 
(see below) it is possible that BBP or a BBP-Mud2 dimer plays a role in cytoplasmic 
translational control or RNA decay.  
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Table 1.1. A sub-list of UACUAAC-bearing intronless mRNA associated with BBP  
Gene Name Function  
YMR291W/ TDA1 putative kinase of unknown function 
YIL119C/ RPI1 putative transcriptional regulator 
YDR172W/ SUP35 translation termination factor eRF3 
YCL005W/ LDB16 protein of unknown function 
YLL043W/ FPS1 plasma membrane channel, member of major intrinsic protein 
(MIP) family 
YKL132C/ RMA1 putative dihydrofolate synthetase 
YHR134W/ WSS1 sumoylated protein of unknown function 
YFR042W/ KEG1 Integral membrane protein of the ER 
YER068W/ MOT2 transcription regulation, subunit of the CCR4-NOT complex 
YER109C/ FLO8 transcription factor required for flocculation, diploid 
filamentous growth, and haploid invasive growth 
YBR163W/ DEM1 mitochondrial protein of unknown function 
YBL033C/ RIB1 catalyzes the first step of the riboflavin biosynthesis pathway 
YBR165W/ UBS1 ubiquitin-conjugating enzyme suppressor 
YGL155W/ CDC43 beta subunit of geranylgeranyltransferase type I 
YIR004W/ DJP1 peroxisomal protein import and peroxisome assembly 
                                                                                                              (Hogan et al., 2008) 
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Figure 1.3 Amino acid sequence alignment of yeast Smy2 (YBR172C) and Syh1 
(YPL105C) GYF proteins. Protein sequences obtained from yeast genome database 
(SGD) were aligned by CLUSTAL Omega 
(http://www.ebi.ac.uk/Tools/services/web/toolform.ebi?tool=clustalo). The conserved 
GYF domain was marked in red. The total identity between the two proteins is 7.29%, 
and the similarity is 16.86%. 
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1.7 Smy2 and Syh1 are linked to RNA metabolism and translation.  
     SMY2 and SYH1 share a high degree of sequence and structure similarity, especially 
the N-terminal GYF domain and the conserved C-terminal domains, and are suggested to 
be homologous proteins (Fig 1.3 and Kofler et al, 2005). SYH1 is believed to be the 
SMY2 paralog that arose from the whole genome duplication of baker’s yeast about 100 
million years ago (Kellis et al., 2004). The conserved GYF domain derives its name from 
the presence of conserved glycine, tryptophan and phenylalanine residues (consensus: W-
X-Y-X6-11-GPF-X4-M-X2-W-X3-GYF), is present in a diverse set of proteins found in 
most or all eukaryotic species (Kofler and Freund 2006). The GYF structure is believed 
to act as a small adaptor domain that mediates protein interactions through the 
recognition of the proline-rich sequences. Peptide binding studies identify the general 
recognition motif for the Smy2 and Syh1 GYF domains is PPGJ, where J stands for a 
hydrophobic residue (Kofler et al, 2005). Although the binding specificities and targets of 
GYF proteins have been investigated, comparatively little is known about the cellular 
roles of most GYF-containing proteins. The most well studied GYF protein is human 
CD2BP2, a protein which interacts with T-cell surface protein CD2 in T lymphoid 
signaling. CD2BP2 also associates with U5 snRNP during U4/U6.U5 tri-snRNP 
formation (Laggerbauer et al., 2005). The CD2BP2 homolog in budding yeast is Lin1, 
which is a non-essential component of U5 snRNP and has physical interaction with the 
U5 protein Prp8 (Stevens et al., 2001). A yeast two-hybrid screen also revealed Lin1 
interactions with factors involved in chromosome segregation, mRNA splicing and DNA 
replication (Bialkowska and Kurlandzka, 2002). In addition, the Lin1 homolog in C. 
elegans has been shown to directly bind splicing factor U2AF65, indicating contribution 
to splicing across a wide array of organisms (Wang et al., 2012).   
SMY2 was first identified as a multi-copy suppressor of myo2-66, a mutation in a gene 
encoding a yeast class V cytoplasmic myosin (Lillie and Brown, 1994). A major function 
of Myo2 is in the transport of secretory vesicles and organelles.  Similar to what was 
found for MYO2, SMY2 was also identified as a multi-copy suppressor of the mutations in 
SEC23 and SEC24, which encode the subunits of the Sec23/Sec24 subcomplex involved 
in coat protein complex II (COPII) vesicle formation (Higashio et al., 2008; Buchanan et 
al., 2010). In addition, SYH1 was also identified as a dosage suppressor of mutations in 
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YPT6 and RIC1 genes, which likewise encode proteins relevant to vesicle transport 
(Georgiev et al., 2008). A recent study suggests that in addition to functioning in 
vesicular transport, Myo2 associates with a larger RNA-protein complex containing 
components of RNA Processing-body (P-body), the site of mRNA degradation and 
translation arrest (Chang et al., 2008; Sheth and Parker, 2003). A second related yeast 
myosin V protein, Myo4, has been shown essential for the transport of a small set of 
localized mRNAs to the bud tip to differentiate daughter cells from mother cells 
(Provance and Mercer, 1999). Interestingly, the Smy2 and Syh1 proteins co-localize with 
the P-body under stress conditions and physically interact with many RNA decay 
components (Georgiev et al, 2007; Ash et al., 2010). While highly speculative, this 
observation raises the possibility that Smy2 and Syh1 might target the RNA substrates, 
potentially BBP-associated, to cytoplasmic P-bodies for storage or degradation, with 
localization potentially mediated by Myo2 function.   
In addition to binding to BBP, Smy2 and Syh1 appear to bind another splicing factor 
containing the proline-rich GYF binding site, Prp8. The prediction of Smy2 and Syh1 
interaction with Prp8 is based on direct peptide binding and their affinity copurification 
(Georgiev et al, 2007; Ash et al., 2010). Prp8 is a highly conserved essential RNA-
binding protein located at the catalytic core of the spliceosome (Grainger and Beggs, 
2005). It is not clear at all what function Smy2/Syh1-Prp8 interaction serves. Although by 
extrapolation with the suggestion for the BBP-association, it is possible that this 
interaction is relevant to the removal of Prp8-associated RNA which might include the 
U5 snRNA, pre-mRNA or the excised intron. A genome-wide yeast two-hybrid study also 
revealed Smy2 and Syh1 interactions with translation initiation factors Eap1, Tif34 and 
Tif35 (Ito et al., 2001). Recently, Smy2, with translation inhibitor Eap1 and RNA binding 
protein Scp160 and the 40S ribosomal subunit Asc1, were found together to inhibit 
translation initiation of POM34 mRNA only in response to spindle pole body defects 
(Sezen et al., 2009). These genetic and biochemical interactions expand the possible 
function of Smy2 and probably Syh1 in translational regulation.  
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1.8 Project overview 
    BBP is essential for yeast cell viability. However, only minor to modest splicing 
defects were detected in certain strong bbp mutants, and BBP is dispensable for in vitro 
splicing (Rutz and Seraphin, 2000; Wang et al., 2008). The mammalian BBP/SF1 protein 
likewise appears to be not essential for in vitro splicing (Tanackovic or Krämer, 2005). 
Consequently, the indispensability of BBP in vivo might be due to a critical function other 
than splicing. This is unlikely due exclusively to the retention of pre-mRNA to the 
nucleus, since other mutants defective in pre-mRNA nuclear retention only have slight or 
modest growth inhibition (Galy et al., 2004). However, it has been noted that the splicing 
of introns mutated at the 5’ splice site or BPS is more sensitive to bbp mutations, 
suggesting a possible requirement for the splicing of natural pre-mRNAs with sub-
optimal splicing substrates (Rutz and Seraphin, 2000; Wang et.al, 2008). Another 
possibility is that BBP, like other STAR proteins, functions outside of the spliceosome 
cycle in a yet-to-be-defined function, possibly involving its cytoplasmic binding partners, 
Smy2 and Syh1.  
     Based on the available information, we proposed a simple initial model in which RNA 
bound by BBP or the BBP-Mud2 complex has its fate influenced by Smy2 or Syh1 
function (Fig 1.4). Here, the association of Smy2 or Syh1 is suggested to promote 
enhanced turnover or impaired translation of the targeted mRNAs. The experiments 
presented below investigate the function of Smy2 and Syh1 in the abundance, stability 
and translation of potential mRNA substrates and test the biological relevance the 
proposed BBP-Smy2, Syh1 interactions.   
 
                                                                                             Copyright © Min Chen 2013 
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Figure 1.4. The hypothetical model of BBP and Smy2/Syh1 cooperation in regulating 
cytoplasmic RNA fate. A single yeast cell is presented. Within the cell, BBP and Mud2 
participate in the nuclear splicing and pre-mRNA retention. A certain proportion of BBP, 
maybe bound with Mud2, associates with mRNA and interacts with Smy2/Syh1 in the 
cytoplasm. The protein-RNA complex is directed to P-body or/and translation machinery 
for the regulation of gene expression.   
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Chapter 2 Materials and Methods 
                                     
Table 2.1 The list of oligos referred in this study 
Name Sequences (5’-3’) 
BBP C-Term Del-1 TTCCGTCGAGTTATTGTCATAACG 
BBP C-Term Del-2 TAATAATACACTCCCATTATACAATATCTGCAT 
PAS2-BBP deltaC-dn  CCAAGCTAATTCCGGGCGAAT 
BBP DraI-up ATCATAAAAGGTACGATTGTCCAAACA 
BBP DraI-dn AAAGGAGGTTCCGTCGAGTTATTG 
KanC TGATTTTGATGACGAGCGTAATGG 
SMY2 300bp dn-RV CGTTATGGTTTGTAAAGAAATTTGCT 
SYH1 300bp dn-RV CACTTCTCATCTCCATTAAGAACC 
TOR1 300bp dn-RV CCATATTTGATCCAAACTTTGACTTG 
MLP1 300bp dn-RV TCGTTTGGTGGGTGGAACA 
BBP 300bp dn-RV TGATGATATCGATGATGACAAGCC 
UPF1 100bp up -FW CTTGTCAGCCAACAAACGTTGAAG 
UPF1 100bp dn -RV GCGCTCATTTCACGGTTGAGC 
RPS29b (-399-167)- FW GAGACAAGGGACGTGTATGCAG 
RPS29b (-399-167)- RV CTGTACTTGTGGAAACCAATGTCG 
RPL21a (26-736)- FW CCTATGAATCTACAGCACGAACG 
RPL21a (26-736)- RV ACGCTTAGCAGCATTGGCC 
his3AI-up GGTCCCCTAGCGATAGAGCACTCG 
his3AI-dn 
 
 
CGCAGACAATCAACGTGGAGGGTA 
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Table 2.1 The list of oligos referred in this study (continued) 
his3-RT primer CAGAGCAGAAAGCCCTAGTAAAGCGTAT 
SMY2 350bp up-PstI TTTTT-CTGCAG-TTGCTCTCAATTTCTTTATACATCTG 
SMY2 450bp dn-SacI TTTTT-GAGCTC-TTGGCTCCTCAGATAAACCTTC 
SYH1 5000bp up-PstI TTTTT-CTGCAG-GTCCGAAGATCAAATTTTTCCC 
SYH1 450bp dn-SacI 
TTTTT-GAGCTC-
GGTTATATTGACAAGTAGTGCTCTTTG 
SYH1 ORF-FW BamHI CCCCGGGGATCCGA ATGAATCCTATCAACTCTCT 
SYH1 ORF-RV BamHI CCCCGGGGATCC TCAAAATCTTTTTCCTTTCT 
TIF34-600bp up GTAGAAGGATCCAGTTTTGTGAGTAGTCAGA 
TIF34-600bp dn GTGTCAGGATCCATCCCGATGGTGATGG 
YGR161C-D -1 CAACAGGAAACGTGACGGTACTC 
YGR161C-D -2 CGTACCAGTTCGCTCCACTTTG 
TDA1 BPS mut-1 
TAACGATTATGATACGACAAATGATAAGAATCCTGCA
AGA 
TDA1 BPS mut-2 
TAACGATTATGATACGACAGCTGATAAGAATCCTGCA
AGA 
TDA1 BPS mut-RV ATGGCTGTGGTATCATTGCTGCTCATCG 
TDA1 -FW GGCGG GTCCTCTGAAACTTCCA 
PGK1-FW GTTGCTGCTTTGCCAACC 
PGK1-RV CTGGGGCAGAAGCCTTG 
RPL9A-FW CTTCACCAAGGTCAACAACCAAT 
RPL9A-RV CGTTGGTGGAAAATTCGATAG 
MEP2-FW TATTGTCCTATTGCATGCTGGGT 
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Table 2.1 The list of oligos referred in this study (continued) 
MEP2-RV ATAACCATCCATGTCAAGCCAC 
Change BP-up1 
GGACCGTGGTTCTGAGTACACGAATAGAACTCTCCA
TAAA 
Change BP-up2 
GGACCGTGGTTCTGAGTACACGGCTAGAACTCTCCA
TAAA 
Change BP-dn AAACTTGATTAGGGTGATGGTTCACGTAGTG 
BJC573 BPseq-1 ACTGATGAGACAACAAAATTGCGT 
BJC573 BPseq-2 CGATTGCAGAGAACCATAAATGG 
RP51A exonII RB1 CGCTTGACGGTCTTGGTTC 
     All the oligos listed for this study were designed using Vector NTI software 
(Invitrogen) and purchased from Eurofins MWG Operon. The stock concentration is 
100µM. 
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Table 2.2 The list of plasmids referred in this study 
Name Descriptions 
pRS414-BBP Obtained from Dr. Michael Rosbash.  
YCplac33-BBP 
Fragment including 450bp upstream + BBP ORF + 500bp 
downstream was recovered from pRS414-BBP with Sac I & Sal I 
digestion, and ligated into the same restriction sites on YcpLac33 
vector. 
pRS414-bbp∆C 
The 363-476AA on the C-terminus of BBP C-terminus on pRS414-
BBP was removed by inverse PCR using BBP C-Term Del-1 and 
BBP C-Term Del-2 oligos. The clone was confirmed by sequencing 
using the oligo BBP DraI-up. 
pRS414-bbp∆56 (Wang et al. 2008) 
pAS2-BBP (Wang et al. 2008) 
pACT-MUD2 (Wang et al. 2008) 
pACT-SMY2 (Wang et al. 2008) 
pAS2- bbp∆C 
The 363-476AA on the C-terminus of BBP C-terminus on pAS2-BBP 
was removed by inverse PCR using BBP C-Term Del-1 and pAS2-
BBP delta C-dn oligos. The clone was confirmed by sequencing 
using the oligo BBP DraI-up. 
YCplac33-SMY2 
SMY2 ORF plus 350bp upstream and 450bp downstream region was 
amplified from genomic DNA by PCR using SMY2 350bp up- PstI 
and 450bp dn- SacI primers, and inserted into the indicated sites on 
YCplac33-vector. 
YCplac111-SYH1 
SYH1 ORF plus 500bp upstream and 450bp downstream region was 
amplified from genomic DNA by PCR using SYH1 500bp up-PstI 
and 450bp dn-SacI primers, and inserted into the indicated sites on 
YCplac111-vector. 
YEplac181-SYH1 
SYH1 ORF plus 500bp upstream and 450bp downstream region was 
amplified from genomic DNA by PCR using SYH1 500bp up-PstI 
and 450bp dn-SacI primers, and inserted into the indicated sites on 
YEplac181-vector. 
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Table 2.2 The list of plasmids referred in this study (continued) 
p425GAL1-SYH1 
SYH1 ORF was amplified from DNA by PCR using SYH1 ORF-FW 
BamHI and SYH1 ORF-RV BamHI， and inserted into the BamHI 
site on p425GALL-vector. 
YEplac181-TIF34 
TIF34 ORF plus 600bp upstream and 6000bp downstream region was 
amplified from genomic DNA by PCR using TIF34-600bp up and 
TIF34-600bp dn oligos, and inserted into the BamHI site on 
YEplac181-vector. 
pBJC-573 Ty1 reporter plasmid for transposition frequency analysis, obtained from Dr. David Garfinkel (Nyswaner et al., 2008). 
pBJC-573-1 
Point mutations underlined (CACGAAT) were introduced into the 
TACTAAC motif in the coding region of the Ty1 reporter pBJC-573 
construct by inverse PCR using the oligos Change BP-up1 and 
Change BP-dn. The clone was confirmed by sequencing using oligos 
BJC573BPseq-1 and BJC573BPseq-2. 
pBJC-573-2 
Point mutations underlined (CACGGCT) were introduced into the 
TACTAAC motif in the coding region of the Ty1 reporter pBJC-573 
construct by inverse PCR using the oligos Change BP-up2 and 
Change BP-dn. The clone was confirmed by sequencing using oligos 
BJC573BPseq-1 and BJC573BPseq-2. 
pGAL1-ORFs The pGAL1-ORF constructs, if not specified, are all from OpenBiosystems (Gelperin et al., 2005). 
pGAL1-tda1-1 
Point mutations underlined (GACAAAT) were introduced into the 
TACTAAC motif in the pGAL1-TDA1 construct by inverse PCR 
using the oligos TDA1 BPS mut-1 and TDA1 BPS mut-RV. The clone 
was confirmed by sequencing using the oligo TDA1 -FW. 
pGAL1-tda1-2 
Point mutations underlined (GACAGCT) were introduced into the 
TACTAAC motif in the pGAL1-TDA1 construct by inverse PCR 
using the oligos TDA1 BPS mut-2 and TDA1 BPS mut-RV. The clone 
was confirmed by sequencing using the oligo TDA1 -FW. 
     All the plasmids were maintained in the TG1 or DH5α E.coli strains, and stored in LB-
Amp medium with 15% glycerol at -80°C.  
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Table 2.3 The list of yeast strains referred in this study 
Strains Genotype Source 
BY4742 MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 OpenBiosystems 
smy2∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
smy2::KAN 
OpenBiosystems 
syh1∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
syh1::KAN 
OpenBiosystems 
smy2∆syh1∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
smy2::KAN syh1::KAN 
this study 
upf1∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
upf1::KAN 
OpenBiosystems 
upf1∆smy2∆syh1∆ 
haploid, his3∆1 leu2∆0 ura3∆0 
upf1::KAN smy2::KAN syh1::KAN 
this study 
mlp1∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
upf1::KAN 
OpenBiosystems 
mlp1∆smy2∆syh1∆ 
haploid, his3∆1 leu2∆0 ura3∆0 
mlp1::KAN smy2::KAN syh1::KAN 
this study 
tor1∆ 
MATα, his3∆1 leu2∆0 lys2∆0 ura3∆0 
tor1::KAN 
OpenBiosystems 
SH121: tor2-21ts 
MATA, leu2-3,112 ura3-52 trp1 his4 rme1 
ade2 tor2::ADE2-3 YCplac111-tor2-21ts 
Dr. B. Dickson 
SH221: tor1∆tor2-21ts 
MATA, leu2-3,112 ura3-52 trp1 his3 his4 
rme1 ade2 tor1::HIS3 tor2::ADE2-3 
YCplac111-tor2-21ts 
Dr. B. Dickson 
smy2∆syh1∆tor1∆ 
haploid, his3∆1 leu2∆0 ura3∆0 
smy2::KAN syh1::KAN tor1::KAN 
this study 
smy2∆syh1∆tor2-21ts 
haploid, leu2 ura3 tor2::ADE2-3 
smy2::KAN syh1::KAN/ YCplac111-tor2-
21ts 
this study 
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Table 2.3 The list of yeast strains referred in this study (continued) 
smy2∆syh1∆tor1∆tor2-
21ts 
haploid, leu2 ura3 tor1::HIS3 
tor2::ADE2-3 smy2::KAN syh1::KAN/ 
YCplac111-tor2-21ts 
this study 
MGD353-46D 
MATα, ura3-52 trp1-289 leu2-112,113 
his3∆1 
Dr. M. Rosbash 
BBP (URA3) 
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
msl5::KAN/ Ycplac33-BBP 
this study 
BBP (TRP1) 
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
msl5::KAN/ pRS414-BBP 
this study 
bbp∆C (TRP1) 
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
msl5::KAN / pRS414- bbp∆C 
this study 
bbp∆56 (TRP1) 
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
msl5::KAN / pRS414- bbp∆56 
This study 
BBP-DAmP 
MATA his3∆1 leu2∆0 ura3∆0 met15∆0 
BBP-DAmP 
OpenBiosystems 
bbp∆Csmy2∆syh1∆ 
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
msl5::KAN smy2::KAN syh1::KAN/ 
pRS414- bbp∆C 
this study 
upf1∆bbp∆C  
haploid, his3∆1 leu2∆0 ura3∆0 trp1-269 
upf1::KAN msl5::KAN / pRS414- bbp∆C 
this study 
TDA1-TAP 
MATA, his3Δ1 leu2 Δ0 ura3Δ0 met15 Δ0 
TDA1-TAP 
OpenBiosystems 
smy2∆syh1∆ TDA1-TAP 
MATα, his3∆1 leu2∆0 ura3∆0 smy2::KAN 
syh1::KAN TDA1-TAP 
this study 
PGK1-TAP 
MATA, his3Δ1 leu2 Δ0 ura3Δ0 met15 Δ0 
PGK1-TAP 
OpenBiosystems 
DJP1-TAP 
MATA, his3Δ1 leu2 Δ0 ura3Δ0 met15 Δ0 
DJP1-TAP 
OpenBiosystems 
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Table 2.3 The list of yeast strains referred in this study (continued) 
RPI1-TAP 
MATA, his3Δ1 leu2 Δ0 ura3Δ0 met15 Δ0 
RPI1-TAP 
OpenBiosystems 
PJ69-4A 
 
MATA, trp1-901 leu2-3,112 ura3-52 his3-
200 gal4∆ gal80∆ LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
Dr. E. Craig 
     All the yeast strains were stored in YPD or synthetic complete medium with 30% 
glycerol and frozen at -80°C. 
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2.1 Yeast techniques  
Yeast strains and media: All yeast strains used in this work are listed in Table 2.3. The 
original wild-type strain (BY4742) and the single gene knockout strains were purchased 
from OpenBiosystems. The double, triple and quadruple mutants were created using 
standard yeast genetic techniques (Sherman F., 1986), confirmed by allele-specific 
polymerase chain reaction (PCR) using KanC upstream and gene-specific downstream 
oligos. Yeast cultures were generally cultivated at 25°C in either rich media (1% bacto 
yeast extract, 2% bacto peptone and 2% carbon source) or appropriate selective media 
(0.7% yeast nitrogen base, indicated CSM dropout powder (Sunrise), and 2% carbon 
source /liter). Plasmids were introduced into yeast strains by the standard lithium acetate 
transformation technique (Ito et al. 1983). The removal of URA3-based yeast vectors 
were achieved by streaking the cultures on 1g/L 5 fluroorotic acid (5-FOA) medium 
(Bender and Pringle 1991).  
Growth rate assay: Overnight cultures in appropriate media were diluted to OD600=0.05 
in the same media, and pre-grown for a further 2~3h at the indicated temperatures. The 
culture density was then measured at 600 nm using a spectrophotometer at 4~6h intervals 
for 18 to 24 hours or until the cultures reached the stationary phase.  
Yeast two-hybrid assay: The yeast two-hybrid host strain (PJ69-4A) was transformed 
with the GAL4 activation domain plasmid pACT2-vector and GAL4 DNA binding 
plasmid pAS2–vector (Clontech Laboratories Inc.), or their derivatives. The interaction 
strength was scored by colony size at 30°C on the histidine-deficient medium containing 
5mM or 20mM 3-aminotriazole (James et al. 1996). 
 
2.2 E. coli techniques 
The E. coli strain used in this study is the TG1 (genotype: K-12 supE thi-1 Δ(lac-proAB) 
Δ(mcrB-hsdSM)5, (rK-mK-) F' [traD36 proAB+ lacIq lacZΔM15]). TG1 competent cells 
were made following the calcium chloride treatment method, and served for the sub-
cloning or yeast plasmid recovery purposes. Cells were routinely cultured @ 37°C in 
Luria Broth (LB, 1% bacto tryptone, 0.5% bacto yeast extract, 1% NaCl) media 
supplemented with 100mg/L ampicillin or other indicated antibiotics when necessary. 
29 
 
The plasmids were recovered from TG1 using the small-scale alkaline lysis protocol 
(Sambrook KJ 1989).  
 
2.3 DNA Analysis 
Yeast DNA preparation: All the yeast DNA samples were prepared using the 
MasterPure™ Yeast DNA Purification Kit (Epicentre Biotechnologies) with RNase 
treatment. The samples were then further purified by phenol: chloroform: isoamyl alcohol 
(25:24:1) extraction and ethanol precipitation. The DNA concentration was estimated by 
OD260 readings.  
Plasmid mutagenesis: Point mutations or deletions were introduced by inverse PCR 
using mutagenesis oligos. Phusion high-fidelity DNA polymerase (New England BioLabs) 
was used for inverse PCR according to the manufacturer’s instructions. The PCR product 
was separated on 1% low-melting agarose gel in 1x TAE buffer (4.84g of Tris base, 
11.4mL of glacial acetic acid and 0.37g of EDTA per liter) and recovered using the 
QIAquick Gel Extraction Kit (Qiagen). The purified PCR products were phosphorylated 
with polynucleotide kinase and ATP before ligation.  
Southern blot analysis: Yeast genomic DNA was digested with the desired restriction 
enzymes, and separated on a 1% agarose gel in 1x TBE buffer (10.8g of Tris base, 5.5g 
of Boric acid and 20mM EDTA). The gel was soaked in 1x Denaturing solution (87.7g 
NaCl, 20g NaOH, pH~13.0) for 1 hour and then in 1x Neutralizing solution (87.7g NaCl, 
157g Tris, pH7.5) for another hour before membrane transfer. The membrane was 
hybridized with gene-specific random primed probes using Random Primer Labeling Kit 
(Invitrogen) in the hybridization solution (6xSSC, 0.05M NaH2PO4, 1% SDS and 5x 
Denhardt), visualized with a Typhoon 9600 phosphorimager (GE Biosystems) and 
analyzed with ImageQuant software. 
 
2.4 RNA analysis 
Northern blot analysis: Total RNA was prepared by breaking yeast on a bead beater 
machine (Biospec Products, Inc.) with sterile glass beads for 4 minutes followed by 
multiple extractions with phenol: chloroform: isoamyl alcohol (25:24:1) and ethanol 
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precipitation. RNA was separated on a 1% agarose/formaldehyde gel in 1x MOPS buffer 
(20mM MOPS pH7.0, 8mM sodium acetate and 1mM EDTA pH8.0). The hybridization 
and detection procedures used were the same as used for Southern blot analysis.  
 
Primer extension analysis: The intron-bearing HZ18 or its derivative constructs (Teem 
and Rosbash, 1983) were introduced into the yeast strains of interest. Yeast were cultured 
overnight in 2ml CSM media lacking uracil with galactose as the carbon source at room 
temperature. The next morning, 25ml of fresh media was added to the cultures to achieve 
an OD600=0.05 and incubation continued at room temperature till OD600=0.5. For gene 
induction experiments involving other GAL1-driven genes, the yeast were first cultured in 
20ml CSM media lack of uracil with glucose as the carbon source till mid-log phase, and 
then shifted to the galactose media at OD600=0.4. Yeast cells were then harvested at the 
desired time points. Total RNA was prepared as described above. Primer extension was 
performed on 12-24µg of total RNA using a 32P-labeled RPS17A exon II primer RB1 
(5’CGCTTGACGGTCTTGGTTC3’) and AMV reverse transcriptase (Life Sciences) at 
42°C for 0.5 hour (Rymond et al. 1990). The cDNA products were separated on a 5% 
polyacrylamide, 7M urea denaturing gel and visualized with Typhoon 9600 
phosphorimager (GE Biosystems). 
 
RNA half-life measurement: For the RPS17A pre-mRNA half-life measurements, yeast 
containing the HZ12 reporter (Teem and Rosbash, 1983) were cultivated continuous in 
CSM media lack of uracil with galactose at low or high cell density at room temperature. 
Yeast cells were resuspended in 20ml of CSM medium lack of uracil (without sugar 
source). 1ml of 40% glucose (2% final concentration) was then added, and cells were 
harvested at the indicated time points. Total RNA was prepared and subjected to primer 
extension analysis as described above.      
    For the TDA1 and PGK1 half-life measurements, yeast strains were transformed with 
pGAL1 reporter constructs. An overnight culture was prepared in 20ml of galactose-based 
CSM media lack of uracil, and diluted to OD600=0.05 in 200ml of fresh medium the next 
day. Yeast cells were harvested when OD600 reached 0.4~0.6 by centrifugation, and 
resuspended in 20ml of CSM medium lack of uracil (without sugar source). 1ml of 40% 
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glucose (2% final concentration) was added. Cells were then harvested at the indicated 
time points after glucose addition. Total RNA was prepared and analyzed for reporter 
transcript abundance by northern blot (Coller, 2008).   
RT-PCR analysis: The total RNA prepared as described was treated with the RNase-free 
DNase (promega) at 37°C for 30 min. cDNA was made using ProtoScript® M-MuLV 
First Strand cDNA Synthesis Kit (NEB) as described. The cDNA samples were then used 
directly as template for PCR reaction. 
 
2.5 Protein Analysis 
Rapid yeast protein preparation: Yeast cultures were grown to the desired OD600 in the 
appropriate medium at room temperature (or as indicated), and harvested by 
centrifugation (total OD600 of 5.0). Cells were treated with 500µl of 2M LiAc and 0.4M 
NaOH for 5 min on ice respectively. The pellet was then resuspended in 100µl/OD600 
SDS-PAGE sample buffer (50mM Tris-HCl pH6.8, 2% SDS, 10% glycerol, 0.005% 
bromphenol blue, and 2.5% β-Mercaptoethanol) and boiled for 5 min. The supernatant 
was recovered after centrifugation, and stored at -80°C if not used directly (Zhang et al. 
2011).  
Western blot analysis: The protein sample (5-10µl) were resolved by 7.5% or 10% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in the running buffer (25mM Tris, 
192mM glycine, 0.1% SDS), and electro-transferred to a PVDF membrane in transfer 
buffer (25mM Tris, 192mM glycine, 10% methanol) at 250mA for 1 hour at 4°C. The 
membrane was pre-blocked in 5% milk in 1xPBS for half hour.  
     For the detection protein A-tagged proteins, horseradish peroxidase-anti-peroxidase 
(PAP, Sigma) was used in a 1:2000 dilution and detected with the SuperSignal West Pico 
Chemiluminescent Substrate Kit (Thermo Scientific). For the detection of Rpl3 protein 
(loading control), mouse anti-Rpl3 primary antibody (Vilardell and Warner 1997) was 
used at a 1:2000 dilution, followed by a 1:5000 diluted goat anti-mouse IgG (H+L)-
alkaline phosphatase conjugate (GIBCO BRL), and detected with BCIP/NBT color 
development substrate (Promega). The protein bands were quantified using the Image 
Studio Lite Ver3.1 software (LI-COR Biosciences).  
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In vitro protein Labeling Assay: Yeast culture were grown in 100ml of CSM medium 
lacking of uracil and methionine with 2% raffinose at room temperature to an OD600=0.4, 
harvested by centrifugation, resuspended in 100ml CSM lacking uracil and methionine 
with 2% galactose. The master culture was grown continuously at low cell density 
(OD600=0.4~0.6). 25ml culture was harvested at the each time point after galactose 
induction and cultivated in 10ml CSM lacking uracil and methionine for 15 minutes. 1ml 
20% galactose stock was then added to make the final concentration 2%. Triplicate 1ml 
aliquots were taken at the indicated time points and incubated with 25µCi trans-35S-label 
(ICN) per OD600 unit of cells for 15 min at room temperature. The incorporation activity 
was monitored by trichloroacetic acid (TCA) precipitation or protein gel visualization. 
For TCA precipitation, cells were treated at 90°C in TCA (250µl of a 50% solution to the 
1ml culture) for 20 min and following incubation on ice. The precipitates were then 
collected on GF/C filters, washed twice with 4ml of 7.5% TCA and twice with 4ml of 
ethanol, and counted by scintillation spectrometry. For protein gel visualization, yeast 
protein extract were prepared using Y-PER yeast protein extraction reagent kit (PIERCE) 
and resolved on a 10% SDS-polyacrylamide gel. The gel was first stained with 
Coomassie brilliant blue to reveal the total protein loading, and then dried at 80°C for 2h 
and visualized with Typhoon 9600 phosphorimager (GE Biosystems).  
 
2.6 Ty1 Retro-transposition Analysis 
Ty1 his3-AI mobility assay: The Ty1 reporter pBJC573 (generous gift from Dr. David 
Garfinkel’s lab, Nyswaner et al. 2008) was transformed into the indicated strains, and 
streaked for single colonies on CSM –Ura plate at 25°C. 10ml of medium was inoculated 
with a single colony, and ~1000 cells (~300µl of a 1/10000 dilution) were then 
transferred into 3 individual 1mL cultures and grown till saturation at 25°C. 100 µl of the 
1/10000 diluted cultures was then spread on non-selective plates (CSM -Ura) for total 
viable cell number estimation. In parallel, 500µl of the same saturated culture was spread 
on selective medium plates (CSM –Ura -His) for total His+ (i.e., transposition positive) 
cell number. The Ty1 reporter mobility was then estimated by dividing His+ cell number 
over total cell number (Nyswaner et al. 2008).  
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Northern analysis on Ty1 RNA: Cultures transformed with the pBJC573 Ty1 
transposition reporter were harvested at mid-log phase grown at 25°C, and used for 
northern analysis. The reverse transcriptase encoding domain of Ty1 was amplified from 
genomic DNA by PCR using oligos YGR161C-D-1 and YGR161C-D-2, and used as 
template for random primed probes. Hybridization with this probe reveals the abundance 
of total Ty1 mRNA derived from the chromosomal copies as well as pBJC573 
(Nyswaner et al. 2008).  The unrelated SCR1 gene transcript was probed as a loading 
control.  
Southern analysis on Ty1 cDNA: Yeast from the same cultures used for northern 
analysis were also used for genomic DNA isolation as described above. The DNA was 
then digested with PvuII before the southern analysis. The same Ty1 random primed 
probes used for northern hybridization were used for Southern blot hybridization 
(Nyswaner et al. 2008).  
 
                                                                                           
                                                                                         Copyright © Min Chen 2013 
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Chapter 3 Results 
3.1 SMY2 and SYH1 are not required for cell viability. 
The nuclear splicing factor BBP has no known cytoplasmic function yet it appears to 
interact with two related cytoplasmic proteins, Smy2 and Syh1. Neither SMY2 nor its 
homolog SYH1 is essential for cell viability (Winzeler et al., 1999). Colony growth on 
rich (i.e., YPD) medium at 15˚C, 25˚C, 30˚C and 37˚C did not reveal any obvious growth 
defects in the absence of SMY2 (smy2∆) or SYH1 (syh1∆) (Figure 3.1A and data not 
shown). In addition, deletion of both genes (smy2∆ syh1∆) does not lead to any detectable 
synthetic phenotypes under the conditions assayed (Figure 3.1A and data not shown). In 
liquid medium, all four cultures grow equivalently (Figure 3.1B), with an estimated 
doubling time of 2.1 hours at 25˚C. Thus, SMY2 and SYH1 appear fully dispensable for 
cell viability under standard laboratory conditions.  
 
3.2 Deletion of SMY2 and SYH1 leads to increased pre-mRNA abundance of certain 
intron-containing genes in high density cultures. 
The cytoplasmic Smy2 and Syh1 proteins are reported to physically and genetically 
interact with the two critical nuclear splicing factors BBP and Prp8 in yeast (Kofler et al., 
2005; Wang et al., 2008). Although the biological relevance of these associations is 
unclear, it is possible that Smy2 or/and Syh1 is relevant to the splicing of a select subset 
of non-essential pre-mRNAs or act directly or indirectly as nonessential efficiency factors 
in general splicing. It is clear, however, that both the smy2∆ and syh1∆ single deletion 
mutants and the smy2∆ syh1∆ double mutant mate and sporulate well (data not shown), 
suggesting neither of these proteins plays a critical role in the documented meiotic-
specific splicing (Engebrecht et al., 1991).   
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A.  
 
 
 
 
 
 
 
B.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. SMY2 and SYH1 are not required for cell viability. (A)The cell cultures of 
the wild-type BY4742 strain, smy2 null mutant (smy2∆), syh1 null mutant (syh1∆), and 
smy2 syh1 double mutant (smy2∆ syh1∆) was spotted as 10-fold serial dilutions on YPD 
media and incubated at 25°C till the colonies reached the scanned size. (B) Yeast cultures 
in YPD were measured at OD600 using spectrophotometer every 3 hours. The OD600 
against the time were presented in a semi-log scale plot. 
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In low-density yeast cultures (i.e., OD600<0.6), the splicing efficiency, as scored by the 
mRNA/pre-mRNA (M/P) ratio, of the RPS17A RNA, appears equivalent in wild-type 
yeast (M/P=33) and in cultures bearing deletions of SMY2 (M/P=35), or SYH1 (M/P=30). 
The double deletion mutant might have a slightly higher pre-mRNA signal under these 
conditions (M/P=25), but the difference is very subtle (Figure 3.2A left panel of first 
row). However, when the RNA is isolated from higher density cultures (OD600 2.5 to 3.0, 
Figure 3.2 right panel of first row), the pattern changes.  Overall, the transcript signal 
decreases, consistent with the established down-regulation of ribosomal protein gene 
transcription when nutrients are exhausted from the medium (DeRisi et al., 1997; 
Wullschleger et al. 2006).  In addition to the decreased levels of mRNA, we observe a 
differential accumulation of pre-mRNA among different genetic backgrounds. For the 
RPS17A transcript, the M/P ratio is 7.1 in the wild-type strain, and 5.8 and 7.8 in the 
smy2∆ and syh1∆ single mutant, respectively. In this experiment, a somewhat higher 
mRNA level boots the M/P ratio of the syh1∆ mutant, but the total pre-mRNA signal 
remains comparable to what is seen in the wild-type control culture. In the smy2∆ syh1∆ 
double mutant, the pre-mRNA level is over 2-fold higher than in the wild-type 
background, with an M/P of ratio of 3.0 (versus 7.1 in the wild type). Equivalent results 
were obtained when probed for mRNA corresponding to the small subunit ribosomal 
protein gene, RPS29B, although with this gene, the basal level of unprocessed pre-mRNA 
for all cultures is elevated under both growth conditions (Figure 3.2A, second row). This 
pattern of change, specifically, a disproportionately greater enrichment of pre-RNA in the 
smy2∆ syh1∆ background compared to the wild-type or single mutants, is highly 
reproducible, although the specific M/P ratios observed in high density cultures fluctuate 
somewhat between experiments. In contrast to what we see for RPS17A and RPS29B, less 
profound or no changes in M/P ratios in response to smy2 and syh1 deletions were seen 
for the intron-containing ribosomal protein genes RPS22B and RPL7A (data not shown), 
suggesting gene-specific effects of Smy2 and Syh1. I also assayed the smy2∆ syh1∆ 
effects in the mlp1∆ null background (Figure 3.2A). MLP1 encodes a non-essential 
protein required for the efficient retention of unprocessed reporter gene pre-mRNA in the 
nucleus (Galy et al. 2004). However, I find little or no difference in the level of pre-
mRNA (or the mRNA/pre-mRNA ratio) observed between the wild-type strain and the 
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mlp1∆ mutant in low- or high- density cultures.  In addition, I find no synergistic effects 
on pre-mRNA accumulation when the mlp1∆ mutation was added to the smy2∆ syh1∆ 
background at either growth state (Figure 3.2A), showing that the loss of Mlp1 function 
has little impact under these conditions.  
The upf1∆ null mutant was included in this assay as a positive control for a mutant 
known to result in pre-mRNA accumulation (Sayani et al., 2008). As presented in Figure 
3.2A, elevated pre-mRNA is seen in this mutant when the RNA is isolated at either low- 
or high- density compared to the wild-type control. This observation is consistent with 
the stabilization of unprocessed pre-mRNA when NMD is inactivated.  In yeast, NMD 
appears to be an exclusively cytoplasmic phenomenon and, as such, the elevated pre-
mRNA seen in the upf1∆ culture is believed to reside in the cytoplasm (Sayani et al., 
2008; Kawashima et al., 2009). The introduction of upf1∆ mutation into the smy2∆ syh1∆ 
background seems to further enhance the precursor accumulation as indicated by the 
further decreased M/P ratios (Figure 3.2B). This observation is consistent with Smy2 and 
Syh1 acting in parallel with the NMD pathway in limiting the precursor abundance in 
high density cultures. Taken together, these observations suggest that Smy2 and Syh1 
limits the abundance of select pre-mRNAs, most likely present in the cytoplasm, in high 
density cultures.  
 
3.3 Smy2 and Syh1 deficiencies show synthetic defects with mutations in TOR-
signaling pathway. 
The results presented above show that RPS17A excess accumulation in the smy2 syh1 
null mutant is sensitive to the growth phase of yeast, suggesting that Smy2 and Syh1-
directed activities might be related by the nutrient signaling pathways regulating cell 
growth. The target of rapamycin (TOR) signaling pathway is the central regulator of 
yeast growth (Wullschleger et al. 2006). When nutrition is favorable, TOR-signaling is 
activated and thus promotes growth-related gene expression. Conversely, yeast cells 
response to nutrient depletion and a variety of other unfavorable conditions by down-
regulating TOR activity, resulting in slowed cell growth and division (Smets et al. 2010). 
Ribosomal protein genes are established targets of TOR regulation and the loss of TOR  
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Figure 3.2 Accumulation of pre-mRNA in smy2 and syh1 null mutants at high cell-
density condition. (A) Yeast cells of the indicated genotypes were cultivated in rich 
YPD media at 25°C, harvested at low cell density (OD600 ~0.6) and high cell density 
(OD600 2.5~3.0) phases, respectively. (B) Yeast cells of the indicated genotypes were 
cultivated in rich YPD media at 25°C, harvested at cell density OD600 2.0~2.5 (left) and 
OD600 2.5~3.0 (right), respectively, for each culture. Total RNA was prepared and 
subjected to Northern analysis. The probes specifically against RPS17A and RPS29B 
were used to detect both pre-mRNA (P) and mRNA (M) of the corresponding transcripts. 
The relative ratio of mRNA and pre-mRNA was listed below as M/P ratio. When the 
precursor signal is close to the background level, the M/P ratio is defined as “na”. 
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signaling impacts the biogenesis of rRNA and ribosomal protein mRNA and protein at a 
number of levels (Cardenas et al., 1999). 
The yeast TOR1 and TOR2 genes encode the core components of the TORC1 and 
TORC2 signaling complexes, respectively, which show partial functional redundancy 
(Wullschleger et al. 2006).  TORC1, containing Tor1 or Tor2, regulates the growth-
related processes and is sensitive to rapamycin inhibition (Wullschleger et al. 2006). 
TORC2, containing Tor2, plays a unique role in the cell-cycle dependent polarization of 
the actin cytoskeleton and is insensitive to rapamycin (Schmidt et al., 1996). TOR1 is 
dispensable for cell viability, while TOR2 is essential. Here, I investigated whether the 
smy2∆ and/or syh1∆ mutation exacerbates the growth of yeast with mutations in TOR1 
or/and TOR2. For this, I used the yeast strain SH221 which contains a null tor1 allele and 
a temperature-sensitive tor2-21 allele (obtained from the Dickson lab, also see Helliwell 
et al. 1998). As can be seen in Figure 3.3A, the smy2∆ syh1∆ mutant grows well in all 
temperatures assayed. Consistent with the published literature (Helliwell et al. 1998), the 
tor mutant showed partial growth inhibition at 30°C and lethality at 37°C. Introduction of 
the smy2 or syh1 deletion into the SH221 background does not lead to any synthetic grow 
defects at 30°C and 37°C. We note, however, that the quadruple mutant of smy2∆ syh1∆ 
tor1∆ tor2-21ts did grow somewhat less well than the tor1∆ tor2-21ts mutant at 25°C, and 
this phenotype is more obvious at 30°C. This indicates a genetic interaction of SMY2 and 
SYH1 with the TOR signaling. Importantly, adding back a single-copy of SMY2 
(Ycplac33-SMY2) to the quadruple mutant, at least partially, reversed this phenotype back 
to what is seen in the syh1∆ tor1∆ tor2-21ts triple mutant (Figure 3.3B), confirming that 
the genetic interaction between TOR signaling and SMY2. In addition, additional smy2∆ 
syh1∆ mutations do not exacerbate the growth of tor2-21ts mutant, suggesting that the 
genetic link is specifically between the two proteins and a common function of Tor1 and 
Tor2 (TORC1 signaling). 
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A.  
 
B.   
 
 
 
 
Figure 3.3. Genetic interactions of SMY2 and SYH1 with TOR-signaling components. 
(A) Growth assay of cells with smy2 syh1 null alleles (smy2∆ syh1∆), with tor1 null and 
tor2 temperature sensitive alleles (tor1∆ tor2-21ts), and with their combinational 
mutations on YPD media at 25°C, 30°C and 37°C. (B) Complementation of Smy2 
activity by introducing the YCplac33-SMY2 along with YCplac33-empty control into the 
smy2∆ syh1∆ tor1∆ tor2-21ts quadruple mutant. The indicated cell cultures were spot at 
10-fold dilution series on YPD medium and scored for growth at 25°C and 30°C. 
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3.4 The pre-mRNA accumulation in the smy2 syh1 null mutant is not TORC1 
signaling-dependent. 
The growth stage-sensitive phenotype and genetic interactions with TORC1 signaling 
pathway led to the assumption that enhanced precursor accumulation phenotype in the 
smy2∆ syh1∆ aging culture might be linked to decreased TOR activity. If this is true, 
inactivation of TORC1 signaling will mimic the late-stage phenotype (increased pre-
mRNA abundance) in smy2∆ syh1∆ cells even at the logarithmic growth stage. To test 
this, I measured the pre-mRNA abundance with inhibited TORC1 signaling by rapamycin 
treatment at 25°C. Rapamycin is an immunosuppressant drug that inhibits the TORC1 
activity in yeast and mammalian cells (Cardenas et al., 1999). As presented in Figure 
3.4A, the rapamycin treatment (0.2µg/ml) at different lengths of time does not lead to 
accumulated RPS17A precursor in smy2∆ syh1∆ low density cultures, but does show the 
expected decrease in RPS17A transcript abundance due to transcriptional down-
regulation. As a further indication that the drug treatment was effective, we observed 
increased MEP2 mRNA accumulation and a reduction of RPL9A mRNA with rapamycin 
treatment, consistent with an earlier study (Cardenas et al., 1999). The SCR1 transcript 
was used here as a rapamycin-insensitive control and, as seen, is unresponsive to drug 
addition (Cardenas et al., 1999). Therefore, while genetic interactions at the level of 
colony growth are apparent, the precursor accumulation observed in dense cell cultures 
does not appear to be a simple response to decreased TOR signaling.  
The rapamycin treatment was also performed with higher cell-density cultures – 
admittedly, a condition where TOR signaling is naturally reduced (Figure 3.4B). In this 
experiment we see a modest elevation of pre-mRNA in the smy2∆ syh1∆ background but 
not in the wild type before treatment as presented earlier. The reason that the mRNA to 
pre-mRNA ratio does not change as much in the smy2∆ syh1∆ mutant at high density 
cultures as seen earlier (e.g., Fig. 3.2A) is due to lower culture density (OD600 2.0 to 2.5) 
compared to earlier assays (OD600 2.5 to 3.0) while cells were harvested. The rationale of 
using lower density cultures is that yeast would start with enough transcript abundance to 
remain detectable after rapamycin repression. The addition of rapamycin again leads to 
decrease in the RPS17A and RPL9A mRNA abundance and increase in MEP2 transcript 
as shown in Figure 3.4A. Surprisingly, the RPS17A precursor present in the smy2∆ syh1∆  
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Figure 3.4. Pre-mRNA accumulation in smy2syh1 null mutant is not TORC1-
signaling dependent. The wild-type and smy2∆ syh1∆ cells were grown to (A) early log-
phase or high cell density (B), and treated with 0.2µg/ml rapamycin for the indicated time 
periods before harvest. Total RNA was prepared and subjected to northern blot analysis. 
The probes against each of the indicated genes were used to detect both pre-mRNA (P) 
and mRNA (M) of the RPS17A, MEP2, RPL9A and SCR1 transcripts. The ratio of mRNA 
and pre-mRNA of RPS17A was listed below as M/P ratio.   
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high density culture is not sensitive to rapamycin treatment, suggesting that somehow this 
precursor is stabilized under this condition.  
3.5 No obvious pre-mRNA further accumulation in the smy2∆ syh1∆ mutant under a 
variety of stress conditions. 
   The splicing of ribosomal protein pre-mRNA but not that of other intron-bearing pre-
mRNAs was previously shown to be inhibited when yeast were challenged with amino 
acid starvation by 3-amino-triazole (3-AT) treatment. 3-AT is a competitive inhibitor of 
HIS3-encoded enzyme, and its presence inhibits histidine synthesis (Klopotowski and 
Wiater, 1965). Addition of 3-AT to a logarithmically growing yeast culture results in a 
rapid and specific cellular response to down-regulate ribosome biogenesis at multiple 
levels of gene expression including splicing (Pleiss et al. 2007a). The Guthrie lab 
interprets the pre-mRNA accumulation after 3-AT addition as most likely due to impaired 
pre-mRNA splicing instead of reduced RNA turnover, since this specific accumulation of 
ribosomal protein pre-mRNA transcripts could not be mimicked in yeast strains defective 
in multiple gene impacting RNA turnover, including: RRP6, a component of the nuclear 
exosome (Houseley et al., 2006); RAI1 and RTT103, two components of the Rat1-
mediated nuclear decay (Kim et al., 2004); SKI2, which mediates 3'-5' RNA degradation 
(Frischmeyer et al., 2002); UPF1, a component of the NMD pathway (Leeds et al., 
1991); or XRN1, the evolutionary conserved 5’-3’ exonuclease component of the P-bodies 
(Kenna et al., 1993). A follow-up study from the Chanfreau group indicates that a portion 
of, if not all, the accumulated pre-mRNA after 3-AT treatment is subsequently degraded 
by the cytoplasmic NMD pathway (Sayani et al. 2008).  
Here I tested whether Smy2 and Syh1 influence this cellular response to amino acid 
starvation in rapidly growing cultures (Figure 3.5). In the previous report (Sayani et al. 
2008), wild-type yeast were shown to respond to 3-AT addition with a 2-fold increase in 
RPS29B and RPL21A precursor within 10 minutes of drug treatment. At later time points, 
the level of pre-mRNA drops, even in the continued presence of this drug suggesting 
some level of adaption. The upf1∆ null mutant was included as a control for a mutant 
with elevated levels of pre-mRNA. Compared to the wild-type strain, a higher level of 
RPS29B and RPL21A precursor was obvious in the upf1∆ strain even before treatment,  
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Figure 3.5. The smy2 syh1 null mutant is not sensitive to amino acid starvation. The 
wild-type or smy2∆ syh1∆ mutant were cultivated in YPD at 25°C before adding 50mM 
3-amino-triazole (3-AT), and harvested at 0, 10 and 20 min after treatment. Total RNA 
was prepared and subjected to Northern analysis. The probes specifically against RPL21A 
and RPS29B were used to detect both pre-mRNA (P) and mRNA (M) of the 
corresponding transcripts. The relative ratio of mRNA and pre-mRNA was listed below 
as M/P ratio.   
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and further accumulation (~1.5-fold) was observed after 3-AT addition. The smy2∆ 
syh1∆ mutant culture responded to 3-AT treatment similar to the wild type and without 
the super-accumulation of pre-mRNA seen with the upf1∆ mutant. Thus, removal of 
Smy2 and Syh1 from yeast does not exacerbate the proposed splicing defects seen after 
3-AT addition. Likewise, the loss of Smy2 and Syh1 appears to have little impact on the 
turnover of excess pre-mRNA under these conditions.  
   The results presented above show that the pre-mRNA of certain ribosomal protein 
genes accumulates when cultures approach a density when cell division, and hence 
ribosome demand, decreases. Since impaired growth generally results in decreased 
ribosomal protein mRNA abundance, I next assayed the RPS17A pre-mRNA 
accumulation under other stress conditions, which have been applied in various yeast 
studies (Noree et al. 2010; Buchan et al. 2010; Gasch et al. 2000; Causton et al., 2001; 
Bergkessel et al., 2011). These conditions include: 100µM/ml cycloheximide treatment; 
1M NaCl treatment; 1.5M sorbitol treatment; 2.5M DTT treatment; H20 challenge; YP 
medium (glucose deprivation); low temperature (4°C); hydrogen peroxide (0.3mM H2O2) 
treatment. My expectation was that if the pre-mRNA accumulation is related to nutrient 
or other environmental response, one or more of these conditions might mimic what is 
seen at high cell density and show increases in pre-mRNA in the smy2∆ syh1∆ 
background (compared with wild-type yeast). Yeast cultures were treated with the listed 
conditions for 15 min and 30min and then assayed for the RPS17A precursor abundance 
by northern blot (Figure 3.6).   
Previous transcriptome analysis (Gasch et al. 2000; Causton et al., 2001) show that 
yeast respond to diverse environmental stresses by the induction of stress-related genes 
and the repression of genes involved in growth-related processes. In our study, glucose 
depletion (YP) and nutrient depletion (water) lead to the anticipated decrease in the 
mRNA abundance in the wild-type yeast after 30 minutes of exposure. Under these 
conditions, the RPS17A pre-mRNA does not seem responsive to the treatments as no 
clear pre-mRNA accumulation was observed. The smy2∆ syh1∆ strain behaved 
equivalently to the wild-type yeast. Cycloheximide treatment inhibits translation 
elongation (Dong et al., 2010), which stabilizes the mRNA and pre-mRNA but, again,  
46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Northern analysis of RPS17A pre-mRNA accumulation phenotype in 
smy2 syh1 null cells under other stress conditions. Wild-type or smy2 syh1 null cells 
were stressed with the specified conditions respectively for 0, 15 and 30 min before 
harvest by centrifugation. Total RNA was prepared and subjected to Northern analysis. 
The probes specifically against RPS17A were used to detect both pre-mRNA (P) and 
mRNA (M) of the RPS17A transcripts. The relative ratio of mRNA and pre-mRNA was 
listed below as M/P ratio.   
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without obvious difference in the presence or absence of Smy2 and Syh1. The remaining 
treatments only cause minor or no changes in the mRNA levels. However, in each case, 
the smy2∆ syh1∆ mutant seems to respond similarly with the wild-type control, with little 
or no further RPS17A precursor accumulation. Therefore, the conditions triggering pre-
mRNA accumulation at high cell density remain unclear but likely are distinct from those 
in the general nutrient response pathways. 
 
3.6 Pre-mRNA stability is enhanced in the absence of Smy2 and Syh1.  
If Smy2 and Syh1 act as efficiency factors in splicing, we predicted that the processing 
of mutant pre-mRNA substrates would be further exacerbated by the sym2Δ syh1Δ 
deletions.  To investigate this, we first measured the relative pre-mRNA abundance 
derived from the various RPS17A-derived reporters by the primer extension technique. 
By using a 32P-labeled RB1 primer against the RPS17A exon II region and reverse 
transcriptase, the reporter-derived products (pre-mRNA, lariat intermediate and mRNA) 
can be visualized (Figure 3.7A). The presence of multiple mRNA bands results from the 
presence of multiple transcriptional initiation sites in this construct (Teem and Rosbash, 
1983). The same heterogeneity is present in pre-mRNA, and could be distinguished with 
further electrophoresis. As reported earlier, the RPS17A transcript expressed from the 
wild-type reporter (HZ18) in the wild-type background is spliced efficiently as estimated 
by the relative mRNA abundance over pre-mRNA. Correspondingly, accumulated 
precursor was observed with the 5’ splice site mutant HZ12 (GUAUGU to GUAUAU), 
and branchpoint site (UACUAAC) mutants HZ3 (UCCUAAC), HZ8 (UAUUAAC) and 
HZ10 (UACUACC), at different levels in the wild-type background (with the order of 
splicing efficiency HZ18>HZ8>HZ3>HZ12>HZ10 as previously reported (Teem and 
Rosbash, 1983). Equivalent patterns were found in the smy2∆, syh1∆ and smy2∆ syh1∆ 
mutants (Figure 3.7A). Thus, the intron-bearing mutant substrates do not show synthetic 
defects in the smy2∆ or/and syh1∆ backgrounds that impact either pre-mRNA splicing or 
RNA stability at low cell density.    
    To determine whether the RPS17A-derived reporter behaves similarly with the 
endogenous RPS17A transcript when cultures approach saturation, I monitored the 
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abundance of the precursor of RPS17A reporter in low and high cell-density cultures. The 
5’ splice site mutant HZ12 reporter was applied here, as the steady level of HZ12 
precursor is easily detectable (Figure 3.7A). Yeast transformed with the HZ12 reporter 
were cultivated in galactose-based medium for the indicated time periods, and analyzed 
for the HZ12 transcript abundance by primer extension. When cultured in glucose, little 
or no transcript was detected demonstrating that this promoter is inactive without 
galactose induction (Figure 3.7B, T=0h). The induction kinetics are rather slow, with the 
mRNA reaching maximum abundance by 24 hours (Figure 3.7B, T=24h), which is likely 
due to the slow growth of yeast in the galactose medium. At low cell density (i.e., 
OD600<0.6), similar amount of HZ12 precursor and processed mRNA accumulate in the 
wild-type and the smy2∆ syh1∆ mutant after galactose induction (Figure 3.7B, T=6h and 
12h), indicating that there is no major change in reporter gene transcription, processing or 
RNA stability in the two backgrounds. By 48 hours, however, mRNA abundance has 
decreased in both high-density cultures (i.e., OD600 3.5 to 4.0) while the level of 
unprocessed precursor is elevated 2 fold in the smy2∆ syh1∆ mutant compared to the wild 
type, as indicated by the mRNA/pre-mRNA ratio (Figure 3.7B, T=48h). Thus, the 
abundance of the HZ12 reporter pre-mRNA, like the endogenous RPS17A transcript, is 
sensitive to the presence of Smy2 and Syh1 at high, but not at low, cell density.   
 In principle, the increased pre-mRNA abundance seen in the smy2∆ syh1∆ mutant 
might result from enhanced reporter gene transcription or decreased turnover of the 
transcribed precursor. Previous work by the Rosbash lab showed that pre-mRNA is found 
in two pools, a pool of pre-mRNA that is rapidly converted into spliced mRNA (t ½ < 2 
sec) and a more slowly turned over pool (t ½ =6 min) of unspliced pre-mRNA destined to 
degradation (Elliott and Rosbash, 1996).  The decrease in M/P ratio observed in the 
smy2∆ syh1∆ high density cultures results from increased pre-mRNA accumulation under 
these conditions. The pre-mRNA might accumulate due to inefficient splicing (i.e., a 
“backup in the pre-mRNA splicing reaction”), or by stabilization of the portion of pre-
mRNA known to be normally destined to decay. If the former, we anticipate that the pre-
mRNA stability will be largely unchanged but the slow-decaying pool will increase. 
Alternatively, if the increase is due to enhanced stability, then we anticipate a decrease in 
the rate of turnover of the unspliced pre-mRNA. 
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Figure 3.7. Primer extension analysis of RPS17A reporter-derived transcripts in the 
wild-type and smy2 syh1 null backgrounds. (A) Yeast transformed with the wild-type 
RPS17A reporter HZ18 or its derivatives were grown in selective galactose medium to an 
OD600 of 0.4-0.6, and harvested for total RNA preparation. (B) Yeast carrying the HZ12 
reporter were originally grown in selective glucose medium, and shifted to the 
corresponding galactose medium at the density of OD600=0.4. Cells were harvested at the 
indicated time points after galactose addition, and used for total RNA preparation. (C) 
Yeast carrying the HZ12 reporter were harvested after 48 hour galactose induction as in 
(B), and resuspended to the corresponding glucose medium. Cells were harvested at the 
indicated time points after glucose repression, and used for total RNA preparation. Total 
RNA from (A-C) was subjected to reverse transcription into cDNA using the RB1 primer 
against RPS17A exonII sequences. The cDNA products were separated on a 6% 
acrylamide gel, in which RPS17A pre-mRNA, mRNA and lariat intermediate (LI) could 
be detected. The half-life of pre-mRNA and mRNA in minutes are marked at the bottom. 
The data from two independent experiments of (C) were plotted on a logarithmic scale, 
with the standard deviation marked.  
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To determine if the pre-mRNA was indeed stabilized, we directly evaluated the half-
life of unprocessed pre-mRNA in the presence or absence of Smy2 and Syh1 using the 
HZ12 reporter. After continuous galactose induction for 48h when culture reaches high 
cell density (i.e., OD600 3.5 to 4.0), yeast bearing the HZ12 reporter were shifted to 
glucose-based medium for transcriptional shutoff of the GAL1 promoter, and then 
harvested at the indicated time points for primer extension analysis of the reporter gene 
transcripts. Unlike the slow galactose-induction, the repression of GAL1 transcription by 
glucose is rapid (Johnston et al., 1994). As shown in Figure 3.7C, both pre-mRNA an 
mRNA signals drop quickly after glucose repression, with the estimated pre-mRNA half-
life time (T1/2) presented at the bottom of the figure. The T1/2 of RPS17A-derived pre-
mRNA in this wild-type strain is 2.61 minutes (SD=0.35). Note that the time course used 
here does not permit detection of the short-lived (<2 second) pre-mRNA destined for the 
splicing pathway. It is unclear why the turnover of the longer lived pre-mRNA species 
differs from the 6 minutes reported earlier although but this may reflect differences in 
strain background or the substitution of the HZ12 reporter in place of the HZ18 wild-type 
construct.  Nevertheless, we note that this same reporter shows an increased t½ in the 
smy2∆ syh1∆ background of 4.03 minutes (SD=0.62). A paired t-test analysis provides a 
p-value of 0.042 (<0.05), indicating that this difference is significant. Therefore, the 
increased level of unprocessed RPS17A-derived pre-mRNA present in the high-density 
smy2∆ syh1∆ cultures is due, at least partially, to a >50% increase in pre-mRNA stability. 
 
3.7 The Smy2/Syh1 recognition domain of BBP is not required for BBP function in 
pre-mRNA splicing or the accumulation of pre-mRNA in high density cultures. 
    The newly defined roles of Smy2 and Syh1 in RNA metabolism led us to address the 
relevance of BBP association with these proteins. BBP is an essential gene involved in 
pre-mRNA splicing in budding yeast (Rutz and Seraphin, 2000; Chang et al., 2012). Its 
amino acid sequence is shown in Figure 3.8A, with the Mud2-interacting, RNA-binding 
and proline-rich domains highlighted. Multiple different point mutations in the KH 
domain of BBP result in lethality, indicating that this RNA binding site is necessary for 
BBP function (Rutz and Seraphin, 2000). In contrast, deletion of first 56 amino acids of 
BBP (bbp∆56) inhibits its interaction with Mud2, but results in only modest growth and 
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splicing defects at elevated temperatures (Wang et al., 2008). Little has been reported on 
the role of the proline-rich carboxyl terminal region, which contains six Smy2 and Syh1 
binding motifs and, for other STAR proteins, is implicated in signal transduction (Vernet 
and Artzt, 1997). Therefore, I first determined whether this domain is critical for BBP 
activity.  
    A previous study (Rain et al. 1998) showed that over-expression of a mutant bbp 
construct missing the last 114 amino acids (363-476AA), which contains all six Smy2 
and Syh1 binding motifs (Figure 3.8A), could support the viability of a bbp null (msl5∆) 
mutant without obvious growth defects under standard laboratory conditions. However, 
as this construct was prepared using a high-copy vector, the question remained as to 
whether BBP protein can support efficient growth without the Smy2/Syh1 interacting 
domain when expressed at natural levels. pRS414-BBP is a single-copy centromeric 
plasmid with a wild-type BBP ORF expressed from its natural promoter sequence (a 
generous gift from the Rosbash lab). This construct fully complements the bbp null 
mutation (Figure 3.8B). I introduced the same deletion of the BBP C-terminal coding 
sequence used in the Rain et al. 1998 study into this plasmid, and found that the pRS414- 
bbp∆C construct complements the bbp null mutant at temperatures between 25°C and 
37°C (Figure 3.16B and data not shown). A bbp∆56 allele constructed this same way led 
to the anticipated temperature sensitive (ts) phenotype at 37°C similar to the same 
mutation integrated at the chromosomal BBP locus (Wang et al., 2008), reinforcing the 
similarity of expression between the single-copy plasmid and the genomic integrant copy 
of this gene (Figure 3.8B). Therefore, we conclude that the proposed Smy2 and Syh1 
interacting domain of BBP is dispensable for cell growth under standard conditions.  
We previously reported that BBP interacts with Mud2 and Smy2 by yeast two-hybrid 
assay (Wang et al. 2008). To determine if the truncated BBP∆C loses its interaction with 
Smy2, this BBP deletion was introduced into the pAS2-BBP reporter construct and 
assayed for its interaction with Smy2 by yeast two-hybrid assay in the host strain pJ69-4a 
(James et al. 1996). In contrast with the strong BBP-Smy2 directed growth observed on 
the indicator medium lacking histidine, interaction between the truncated BBP∆C and 
Smy2 was undetectable (Figure 3.8C, top right panel). To further support the view that  
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Figure 3.8. Deletion of Smy2 and Syh1-interacting domain of BBP does not lead to 
obvious growth defects or general splicing inhibition at regular growth conditions. 
(A) Amino acid sequence of MSL5/BBP coding region.  Red: Mud2 binding motif (22-
35AA); Green: KH (146-244AA) and QUA2 (245-269AA) domains; Blue: Proline-rich 
domain (333-476AA), with Smy2 and Syh1 recognition motifs underlined. (B) Growth 
assay of the wild-type BBP strain, bbp N-terminal deletion mutant (bbp∆56) and bbp C-
terminal deletion mutant (bbp∆C) on YPD media at 37°C. (C) Yeast two-hybrid strain 
(PJ69A) with the indicated constructs were scored for their normal growth on medium 
lacking leucine and tryptophan (non-selective) and HIS3 reporter activity on medium 
lacking histidine supplemented with 20mM 3-aminotriazole (3-AT) (selective) at 30°C. 
(D) Yeast cells with the BBP or bbp∆C allele were cultivated in YPD media at 25°C, and 
harvested at low cell density (OD600 0.4~0.6). Total RNA was prepared, and subjected to 
Northern analysis. The probes specifically against RPS17A was used to detect both pre-
mRNA (P) and mRNA (M) of the corresponding transcripts. The relative ratio of mRNA 
and pre-mRNA was listed below as M/P ratio.  
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the pAS2-bbp∆C encodes a stable copy of BBP∆C, I assayed in parallel its interaction 
with Mud2. Since Mud2 binds the N-terminal region of BBP, we expected that BBP∆C 
would still interact with Mud2 and indeed this was the case (Figure 3.8C, bottom right 
panel). In addition, I find that the pAS2-bbp∆C two-hybrid construct itself supports the 
viability of the bbp null mutant (data not shown), showing that bbp∆C encodes a 
functional copy of BBP∆C even as a GAL4-fusion construct. Based on this, we conclude 
that C-terminal deletion of BBP blocks stable association with Smy2 but, similar to the 
smy2 and syh1 deletion mutants, this has little or consequence on growth when assayed 
under standard laboratory conditions 
 Since BBP is required for cellular splicing while its C-terminal interaction with 
Smy2/Syh1 is less obviously associated with splicing, I investigated whether the bbp∆C 
mutation inhibits pre-mRNA processing. Consistent with the near wild type-like growth 
rate, the splicing of RPS17A pre-mRNA in the bbp∆C mutant is still robust at 25°C and 
37°C (Figure 3.8D; Figure 3.10B lane 3 and 4) as indicated by similar mRNA/pre-mRNA 
ratio. At 25°C, the splicing efficiency of RPS17A is equivalent in the BBP and bbp∆C 
strains, with the M/P ratio of 34 and 33 respectively. While at 37°C the overall RPS17A 
pre-mRNA signal is higher, resulting in lower M/P values compared to at 25°C.  
Nevertheless, similar to what is seen at the lower temperature, the M/P ratios remain 
similar at 37C in the wild-type BBP (M/P=13) and the mutant bbp∆C (M/P=12) strains. 
In contrast, when the RPS29B transcript is assayed at low cell density, the bbp∆C 
mutant shows a slightly higher pre-mRNA percentage (M/P=15) compared to the 
isogenic control (M/P=23) (Figure 3.9A left panel), suggesting a minor contribution of 
the BBP C-terminus to splicing or pre-mRNA stabilization. In higher density cultures, 
however, there is no further pre-mRNA accumulation in the bbp∆C mutant (with M/P 
ratio of 5.1) compared to the BBP control (with M/P ratio of 5.2) (Figure 3.9A right 
panel). Therefore, while the BBP C-terminal region may weakly influence pre-mRNA 
splicing efficiency, the elevated pre-mRNA levels in the high-density smy2∆ syh1∆ 
cultures appears not to result from the simple loss of interaction between BBP interaction 
with the GYF domain of Smy2 or Syh1. 
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Figure 3.9. The bbp∆C mutant does not show the pre-mRNA abundance changes 
observed in smy2∆ syh1∆ mutant. (A) Yeast cells with the BBP or bbp∆C allele were 
cultivated in YPD media at 25°C, harvested at low cell density (OD600 0.4~0.6) and high 
cell density (OD600 2.5~3.0). (B) Yeast cells of the indicated genotypes were cultivated in 
rich YPD media at 25°C, harvested at cell density OD600 2.0~2.5 (left) and OD600 2.5~3.0 
(right), respectively, for each culture. Total RNA was prepared from (A) - (B), and 
subjected to Northern analysis. The probes specifically against RPL21A or RPS29B were 
used to detect both pre-mRNA (P) and mRNA (M) of the corresponding transcripts. The 
relative ratio of mRNA and pre-mRNA was listed below as M/P ratio.   
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I also assayed the splicing response of the bbp∆C mutant to amino acid starvation. As 
mentioned above, the addition of 3-AT to growing yeast cultures results in a rapid but 
transient splicing inhibition (Pleiss et al. 2007a). In contrast to the smy2∆ syh1∆ mutant 
which behaves like the wild-type, the bbp∆C mutant shows a higher proportion of 
RPS22B and RPS17A precursor accumulating after 3-AT treatment compared to the wild-
type control (Figure 3.9B). As the 3-AT effect is believed due to splicing inhibition, the 
synthetic enhancement in the bbp∆C mutant background is consistent with an 
exacerbation of this defect, supporting the view that the C-terminal domain of BBP 
modestly impacts splicing efficiency. 
 
3.8 Genetic interaction between upf1, a nonsense mediated decay factor, and bbp∆C.  
    The Seraphin group previously showed that certain bbp mutants have synthetic lethal 
or growth-impaired phenotypes when combined with an upf1 null mutation, with the 
severity of growth inhibition positively correlated with pre-mRNA retention defects in 
the bbp mutants (Rutz and Seraphin 2000). Here I compared the growth of the upf1∆ 
bbp∆C double mutant with wild-type yeast and the single mutants. As shown in Figure 
3.10A, at 25°C all the strains grow similarly. However, at 37°C the upf1∆ bbp∆C mutant 
shows an impaired growth compared to the upf1∆ or bbp∆C single mutant. To investigate 
the differences in splicing efficiency, I scored the M/P ratios in the upf1∆ bbp∆C mutant 
along with the upf1∆ and bbp∆C single mutants at 37°C. Note that the M/P ratio is 
generally lower at 37°C compared to that of at 25°C, which is probably due to somewhat 
inhibited splicing at higher temperature (Wang et al., 2008). As shown in Figure 3.10B, 
the single mutants show similar splicing efficiencies (upf1∆, M/P=11; UPF1, M/P=14; 
bbp∆C, M/P=12; BBP M/P=13). However, I observed a 2-fold decrease of M/P ratio in 
the upf1∆ bbp∆C mutant (M/P=6.3) compared with the bbp∆C and upf1∆ mutant itself 
(M/P=12 and 11, respectively), consistent with the view that the bbp∆C mutation weakly 
impairs splicing and results in enhanced pre-mRNA export from the nucleus into the 
cytoplasm where it is stabilized by the lack of NMD in the upf1∆ background. This 
increase in pre-mRNA is consistent with either modestly impaired pre-mRNA splicing, 
enhanced pre-mRNA export, or both associated with bbp∆C.  Here, as before (Rutz and 
Seraphin 2000), however, the degree of splicing inhibition was modest compared to the 
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growth inhibition observed in the double mutant indicating that the growth inhibition 
does not result from a generalized splicing inhibition. Rather, it may reflect acute 
sensitivity in the splicing of certain transcripts or a secondary effects such as toxicity 
resulting from the translation of noxious peptides from unprocessed pre-mRNA exported 
to the cytoplasm.  
    I assayed the growth of the upf1 null mutant in the smy2∆ syh1∆ double mutant 
background to see if the observed genetic interaction between upf1∆ and bbpΔC extends 
to upf1Δ and these BBP binding partners. I found that the growth of the smy2∆ syh1∆ 
double mutant is similar in the presence or absence of the UPF1 gene at 25˚C and 37˚C 
(Figure 3.11).  In addition, no obvious synthetic defect was observed in the bbp∆C smy2∆ 
syh1∆ triple mutant background (Figure 3.11). Thus, the C-terminal region of BBP binds 
Smy2 and appears to have some function as its removal renders bbp∆C sensitive to the 
upf1 null mutation. However, unlike bbpΔC, the loss of Smy2 or Syh1 appears to further 
stabilize pre-mRNA in the upf1∆ background (Figure 3.2) without significantly inhibiting 
growth suggesting that the bbpΔC synthetic lethality with upf1Δ may not simply be due 
to the presence of pre-mRNA in the cytoplasm.    
 
3.9 Smy2 and Syh1 promote genome stability by restricting Ty1 retrotransposition 
in budding yeast.  
In addition to intron-bearing transcripts, multiple transposon-yeast (Ty) element RNAs, 
containing two UACUAAC motifs, were co-purified with BBP (Hogan et al., 2010). Ty 
elements are mobile DNA sequences that move from one chromosomal site to another via 
an RNA intermediate in a process called retrotransposition (Roeder and Fink, 1982). Ty1 
is the most abundant Ty element in yeast, with 25-35 copies per haploid genome, and 
most of them are transcriptionally and transpositionally competent (Curcio, et.al, 1988; 
Sundararajan et al., 2003). Although Ty1 RNA accounts for 0.1-0.8% of total cellular 
RNA, the rate of Ty1 retrotransposition is only 10-5 to 10-7 events per Ty1 element per 
cell division (Curcio and Garfinkel, 1991). The regulation of transpositional dormancy is 
believed post-transcriptional, at the level of Ty1 protein processing (Curcio and Garfinkel, 
1992).    
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Figure 3.10. Deletion of Smy2 and Syh1-interacting domain of BBP does not lead to 
general splicing inhibition. (A) Growth assay of the wild-type BY4742 strain, upf1 
knockout (upf1∆), wild type BBP strain (BBP), bbp C-terminal deletion mutant (bbp∆C) 
and the double mutant (upf1∆ bbp∆C) on YPD media at 25°C and 37°C. (B) Northern 
analysis of RNA isolated from the indicated low density cultures grown at 37°C, probed 
against RPS17A to detect both pre-mRNA (P) and mRNA (M). The relative ratio of 
mRNA and pre-mRNA was listed below as M/P ratio.   
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Figure 3.11. No synergic interaction of smy2∆syh1∆ mutations with bbp∆C or upf1∆. 
Growth assay of the smy2 syh1double mutant (smy2∆ syh1∆), bbp C-terminal deletion 
mutant (bbp∆C), upf1 null mutant (upf1∆), bbp∆C plus smy2∆ syh1∆ triple mutant, and 
upf1∆ plus smy2∆ syh1∆ triple mutant on YPD media at 25°C and 37°C parallelly.  
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BBP interacts in vitro with the Smy2 and Syh1 proteins (Georgiev et al, 2007), and in 
vivo with at least Smy2 by the yeast two-hybrid assay and by affinity enrichment (Wang 
et al., 2008; Ash et al., 2010). To test if Smy2 or Syh1 plays a role in retrotransposition, I 
applied a well-established Ty1 retrotransposition reporter assay (Nyswaner et al. 2008) to 
score retrotransposition frequency in the presence and absence of SMY2 or/and SYH1. 
This Ty1 reporter (pBJC573, a generous gift from the Garfinkel lab) is a URA3-based 
integrating plasmid that carries a functional Ty1 element marked by a HIS3 gene with an 
artificial intron (AI). The reporter-based HIS3 gene is inserted in the reverse orientation 
with respect to the Ty1 mRNA and the artificially introduced intron. Therefore, the HIS3 
gene can only be stably expressed if the Ty1 reporter transcript is spliced, converted into 
cDNA and then integrated into the genome by retrotransposition (Figure 3.12A). The host 
strain (BY472) used in this assay contains chromosomal his3 and ura3 null mutations. 
Consequently, the Ty1 reporter transposition rate can be estimated by the ratio of URA3 
colonies (i.e., all reporter gene transformants) that are His+ (i.e., successful 
retrotransposition integrants; see materials and methods for more details on this assay).   
The results of the retrotransposition assay are presented in Figure 3.12B. Here, the 
wild-type strain has an average transposition frequency of 6.86 ×10-6, which is roughly 4-
fold higher than seen in an earlier report (Nyswaner et al., 2008), possibly due to changed 
assay temperature (here we used 25˚C instead of the reported 20˚C) or other minor 
experimental variations. The retrotransposition frequency is not significantly changed in 
the smy2∆ or syh1∆ single mutants compared to the wild-type control as evaluated by t-
test analysis. However, the combination of both mutations leads to a ~2.5 fold increase in 
retrotransposition compared to the wild type, with a p-value <0.01. Consistent with an 
earlier report, we also observed a >100-fold decrease in retrotransposition in the upf1∆ 
mutant background (Dutko et al. 2010). We find that introduction of smy2 and syh1 null 
mutations into the upf1∆ mutant enhances retrotransposition 14-fold, indicating a partial 
suppression of the upf1 transposition defect. This is a significant improvement (p-
value<0.001), although we note that retrotransposition remains low, approximately 12% 
of what is seen in a wild-type culture. These observations indicate that Smy2 and Syh1 
directly or indirectly limit Ty1 retro-transposition and thereby promote genome integrity 
in budding yeast.  
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3.10 Ty1 RNA and unincorporated cDNA levels increase in the absence of SMY2 
and SYH1. 
To investigate the steps in Ty1 retrotransposition pathway affected by the absence of 
Smy2 and Syh1, I first determined whether the level of unincorporated Ty1 cDNA differs 
between the wild-type and mutant cultures. Unincorporated Ty1 cDNA is the obligate 
intermediate which is subsequently integrated into the genome to effect retrotransposition 
(Boeke and Chapman, 1991). Genomic DNA prepared from mid-log cultures was 
digested with PvuII, which, as previously described (Nyswaner et al., 2008), generates a 
distinct 2-kb fragment representing unincorporated Ty1 cDNA and multiple >2kb DNA 
fragments from integrated copies of Ty1 DNA. The digested DNA was subjected to 
southern analysis using a 32P-labeled DNA probe against the reverse transcriptase domain 
of Ty1. The detected unincorporated Ty1 cDNA signal is derived mostly from the 
endogenous copies based on previous studies (Curcio, et.al, 1988), although the pBJC573 
reporter is present as well. As previously described for this assay (Nyswaner et al., 2008), 
the relative abundance of unincorporated Ty1 cDNA was normalized against an 
integrated Ty1-genomic fragment (Figure 3.12D).  
    Compared to the wild-type strain, Ty1 cDNA abundance was found to be elevated 
roughly 1.2, 1.7 and 2.2-fold in the smy2∆ mutant, the syh1∆ mutant and the smy2∆ 
syh1∆ double mutant, respectively. This pattern of changes is highly reproducible. The 
change in unincorporated Ty1 cDNA abundance correlates directly (in direction and 
magnitude) with the increase in retrotransposition observed in the smy2/syh1 mutants. 
Consistent with an earlier report (Dutko et al. 2010), I also observed a decrease of ~30% 
of Ty1 cDNA in the upf1∆ mutant. While the Dutko report showed a somewhat higher 
(70%) decrease in Ty1 cDNA, in neither case can the observed reduction in 
retrotransposition be explained by the decrease in cDNA found in the upf1∆ mutant.  
Interestingly, the smy2∆ syh1∆ mutations restore Ty1 cDNA abundance to the wild-type 
level in the upf1∆ mutant, although, as mentioned above, retrotransposition is not fully 
recovered (up to 12% of the wild-type level, Figure 3.12B), suggesting that additional 
Upf1-sensitive steps occur subsequent to cDNA synthesis. 
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     Next, I tested an upstream step in retrotransposition and measured Ty1-HIS3AI 
reporter and total Ty1 RNA abundance in response to decreased Smy2 and Syh1 
activities. The same 32P-labeled DNA probe against the reverse transcriptase domain of 
Ty1 used in Southern blot analysis above was applied to detect the total Ty1 transcript, 
derived from both the genomic and reporter genes. A 32P-labeled DNA probe against the 
HIS3 coding region was used to specifically detect Ty1-HIS3AI RNA, and SCR1 was 
probed to serve as the loading control. As shown in Figure 3.12C (first row), a 1.7-fold 
increase in Ty1-HIS3AI RNA was detected in the smy2∆ mutant and 2-fold increase in 
the syh1∆ mutant, with the smy2∆syh1∆ double mutant having the highest level (2.3-fold 
increase). Upf1 was shown earlier to regulate Ty1 retro-transposition post-
transcriptionally (Dutko et al. 2010), and, consistent with this, while retrotransposition is 
very low, Ty1-HIS3AI RNA levels remain high and are modestly (1.4-fold) elevated in 
the upf1 mutant background. Interestingly, deletions of SMY2 and SYH1 further increase 
(1.54-fold) the Ty1-HIS3AI mRNA abundance in the upf1 null mutant, which may 
contribute to the partial rescue on retrotransposition. Total Ty1 transcript (Figure 3.12C, 
second row), derived mostly from the endogenous copies (Curcio, et.al, 1988), showed an 
almost the same pattern with Ty1-HIS3AI RNA, indicating that the reporter Ty1 
undergoes the same regulations as the endogenous Ty1 genes. These observations 
demonstrate that Smy2 and Syh1 act redundantly in restricting Ty1 retrotransposition 
largely, if not only, through limiting Ty1 RNA abundance. Together with analysis of pre-
mRNA accumulation, these data are consistent Smy2 and Syh1 contributing to the steady 
state levels of multiple distinct cellular RNA species.   
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Figure 3.12. The Ty1 retrotransposition analysis in smy2 and syh1 mutants.  (A) The 
schematic representation of the Ty1 retrotransposition assay using the Ty1-HIS3AI 
reporter (pBJC573). (B) The retrotransposition frequencies of the Ty1-HIS3AI reporter 
were increased in the absence of SMY2 and SYH1. The pBJC573 reporter was introduced 
into the wild-type, smy2∆, syh1∆, smy2∆ syh1∆, upf1∆ and upf1∆ smy2∆ syh1∆ cells 
respectively, and assayed as described in the materials and methods section. The results 
were graphed with standard deviations, and ** indicates a statistical significant difference 
(P<0.01). (C) Both endogenous and reporter Ty1 mRNA were increased in the smy2 and 
syh1 mutants. Total RNA was isolated from mid-log cultures, and subjected to northern 
analysis using probes specifically against HIS3, Ty1 and SCR1 genes. The relative Ty1-
HIS3 and Ty1 RNA abundance was normalized with the SCR1 mRNA signal, and 
represented as Ty1-HIS3/SCR1 or Ty1/SCR1. (D) Unincorporated Ty1 cDNA increases in 
the absence of SMY2 and SYH1. Total DNA was isolated from mid-log cultures, and 
subjected to Southern blot analysis using probes against Ty1. The unincorporated 2kb 
Ty1 cDNA, along with the loading control band were labeled. The relative free Ty1 
cDNA abundance was presented below.  
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3.11 The level of unincorporated Ty1 cDNA decreases in the bbp∆C mutant. 
 I next analyzed the Ty1 retrotransposition in the bbp∆C mutant to see if this mutation 
alters transposition in a manner similar to the smy2Δ syh1Δ deletions. As the endogenous 
free Ty1 cDNA is generally positively correlated with the transposition frequency 
(Nyswaner et al., 2008), I measured the endogenous unincorporated Ty1 cDNA in the 
bbp∆C mutants without the pBJC573 reporter, whose expression requires a splicing step. 
Note that the overall Ty1 banding pattern in the wild-type strain (BY4742), including the 
relative intensity of the unincorporated cDNA, is equivalent here (Fig. 3.13A) as it is 
when the pBJC573 reporter is present (Fig. 3.12), consistent with the reporter 
contributing a comparatively minor percentage of the signal. As shown in Figure 3.13A, 
in contrast with the smy2Δ syh1Δ mutant which shows a 2.2-fold increase in total Ty1 
cDNA, the bbp∆C mutation results in a 47% decrease in Ty1 cDNA. Interestingly, the 
introduction of smy2Δ syh1Δ deletions fully rescues the bbp∆C mutant at the level of Ty1 
free cDNA abundance. The deletion of MUD2, which encodes the protein forming a 
heterodimer with BBP (Wang et al., 2008), results in a 63% decrease in Ty1 cDNA 
(Figure 3.13B). As noted earlier, this assay was conducted in the absence of the reporter 
gene and hence measures only the endogenous Ty1 cDNA. Thus, while there is no known 
splicing dependent step in Ty1 cDNA biogenesis, mutation of either the BBP or Mud2 
splicing factor genes inhibits Ty1 cDNA accumulation. In contrast, removal of the 
interacting Smy2 and Syh1 proteins shows the opposite effect and increases Ty1 cDNA 
levels. 
While neither the bbp∆C nor the mud2∆ mutants show strong general splicing 
inhibition (Wang et al., 2008), it is possible that a subset of intron-containing genes are 
especially sensitive to the bbp∆C and mud2∆ mutations, and inhibit Ty1 
retrotransposition through a splicing sensitive step not yet defined. If this is the case, I 
expected that other splicing mutants would show a similar phenotype. Therefore, I scored 
a subset of nonessential genes previously shown to display splicing defects (refer to table 
3.1), for endogenous unincorporated Ty1 cDNA abundance. It is important to note that 
these are isogenic strains created by genomic mutations in the BY4742 background and 
differ from one another only in the location of the gene deletion. After normalization with 
an internal common Ty1 band, I found a surprising level of variation in the Ty1 cDNA  
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Figure 3.13. Ty1 cDNA analysis on the bbp, mud2 and a subset of splicing mutants. 
(A-C) Total DNA was isolated from (A) the wild-type BBP, bbp∆C and bbp∆C 
smy2∆syh1∆ cultures, (B) the wild-type MUD2 and mud2∆ cultures, and (C) wild type 
and the listed splicing mutant cultures. Southern blot analysis was performed using 
probes against Ty1. The unincorporated 2kb Ty1 cDNA, along with the loading control 
band were labeled. The relative free Ty1 cDNA abundance was presented.  
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Table 3.1. List of splicing mutants assayed for Ty1 cDNA abundance.  
 
* All the mutants above were derived from the BY4742 wild-type strains, with the 
specific gene loci replaced with a KanMX cassette using homologous recombination 
(Winzeler et al., 1999). 
 
 
 
 
 
 
 
splicing mutants references 
bud31∆ 
 
Masciadri et al., 2004 
cbc2∆ 
 
Colot et al., 1996 
csn12∆ 
 
Wilmes et al., 2008 
cus2∆ 
 
Yan et al., 1998 
ecm2∆ 
 
Xu et al., 1998 
isy1∆ 
 
Dix et al., 1999 
lea1∆ 
 
Caspary and Séraphin, 1998 
lsm6∆ 
 
Ryan et al., 2002 
lsm7∆ 
 
Ryan et al., 2002 
lsr1∆ 
 
Ares, 1986 
msl1∆ 
 
Tang et al., 1996 
mud1∆ 
 
Liao et al., 1993 
nam8∆ 
 
Ogawa et al., 1995 
ntc20∆ 
 
Chen et al., 2001 
prp18∆ 
 
Horowitz et al., 1993 
sme1∆ 
 
Beggs, 2005 
snu17∆ 
 
Gottschalk et al., 2001 
snu66∆ 
 
Stevens et al., 2001 
sto1∆ 
 
Lewis et al., 1996 
syf1∆ 
 
Russell et al., 2000 
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levels, with the majority of the mutants showing <1.5 fold increase or decrease (mud1∆, 
snu66∆, ntc20∆, isy1∆, syf1∆, sme1∆, snu17∆, lsm6∆, bud31∆, nam8∆, lea1∆, cus2∆), 
and a few showing more obviously reduced cDNA abundance (msl1∆, lsm7∆, cbc2∆, 
sto1∆) (Figure 3.13C). There were exceptions, however, as some mutants show 1.5-2 fold 
increases (csn12∆, lsr1∆, ecm2∆). The prp18∆ sample always showed high background, 
making it difficult to quantify, but with at least a 3 to 5-fold increase in Ty1 cDNA. In 
any case, my observations show that a decrease in Ty1 cDNA abundance is not a general 
feature of splicing mutants. We note that the endogenous Ty1 RNA has two copies of the 
BBP binding site, and, unlike the Ty1 reporter, it does not possess an intron. Thus, the 
decreased Ty1 cDNA abundance in the bbp∆C and mud2∆ backgrounds may not be a 
consequence of decreased pre-mRNA splicing but relate to some undefined contribution 
of BBP and Mud2 to the Ty1 retrotransposition process. 
 
3.12 Smy2 and Syh1 levels also impact the intronless TDA1 mRNA and protein 
abundance. 
Since removal of Smy2 and Syh1 leads to increased accumulation of Ty1 RNA and 
under certain conditions, increased levels of pre-mRNA for at least two intron-containing 
genes, we were encouraged to investigate if other BBP-associated mRNAs were sensitive 
to the levels of these two cytoplasmic P-body-associated proteins. TDA1 mRNA is an 
intronless mRNA which contains a UACUAAC hepta-nucleotide BBP binding site within 
its protein coding sequence. TDA1 mRNA was found to co-purify with BBP and at the 
highest enrichment index level among UACUAAC-bearing mRNAs in an earlier study 
performed by the Brown lab (Hogan et al. 2008). TDA1 encodes a protein kinase whose 
substrates are largely unknown except for the hexokinase Hxk2, which is involved in 
glucose sensing and in the transcriptional regulation of certain catabolic genes (Kettner et 
al., 2012). Northern blot analysis revealed no obvious changes in TDA1 mRNA level in 
the smy2∆ syh1∆ double mutant compared to the wild type in low cell-density cultures 
when grown in nutrient-rich YPD medium (data not shown). As TDA1 expression tightly 
correlates with cell growth rate (Gasch et al. 2000), northern blotting revealed little or no 
detectable TDA1 mRNA in high cell-density cultures or even at low cell density when 
yeast are cultured in nutritionally defined synthetic complete medium (data not shown). 
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This pattern of transcriptional regulation precluded the direct analysis of Smy2/Syh1 
contribution to TDA1 mRNA stability at high cell density. To circumvent this problem, I 
used a gene fusion approach to express TDA1 from the robust and nutritionally regulated 
GAL1 promoter (pGAL1-TDA1, Gelperin et al., 2005). 
As shown in Figure 3.14A left panel, in glucose medium (T=0h), where pGAL1-TDA1 
transcription is repressed, TDA1 mRNA abundance is very low in the wild type and 
smy2∆ and syh1∆ cultures but slightly elevated in the smy2∆ syh1∆ mutant. 
Hybridization with the SCR1 control transcript (lower panel) as well as the image of 
rRNA (not shown) demonstrate equal sample loading. As expected, galactose addition 
increases TDA1 mRNA derived from pGAL1-TDA1 in a time-dependent manner up to at 
least 24 hours (Figure 3.14A, left panel). Among the four stains, the TDA1 mRNA signal 
is approximately 1.34-fold higher in the smy2∆ mutant and 1.80-fold higher in the smy2∆ 
syh1∆ mutant at T=6h when normalized against the loading control and setting the value 
in the wild-type background to 1.0. At T=12h, the values are 1.94-fold and 2.66-fold 
higher in the smy2∆ and smy2∆ syh1∆ mutants, respectively. For unknown reasons, the 
differences between the wild type and the smy2∆, syh1∆, smy2∆ syh1∆ mutants becomes 
less obvious at T=24h. The syh1∆ mutant responds similarly to the wild type at all the 
tested time points. The corresponding protein analysis (Figure 3.14A, right panel) 
revealed a similar expression pattern as the RNA analysis. The Tda1 protein was easily 
detectable even after 6h induction, and further increased at 12h and 24h time points. 
Consistent with the RNA profile, the average Tda1 protein signals are higher, but not 
statistically significant, in the smy2∆ and smy2∆ syh1∆ mutants at T=6h and 12h. The 
difference with wild type is again less obvious at 24h.  
To test if the Smy2 and Syh1’s effects on TDA1 expression is a phenomenon perhaps 
linked to the generally enhanced expression from the GAL1 promoter rather than a gene-
specific event, I also assayed PGK1 expression from an equivalent construct, pGAL1-
PGK1 (Gelperin et al., 2005). PGK1 mRNA does not possess the UACUAAC BBP-
biding site and this mRNA does not co-purify with the BBP protein (Hogan et al., 2010).  
In contrast to what was observed with TDA1, the PGK1 mRNA and protein levels are 
quite similar at all genetic backgrounds and not detectably increased in smy2∆ and smy2∆ 
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syh1∆ mutants (Figure 3.14B). In this image, the smy2∆ sample at T=6h shows an 
apparent 1.48-fold increase in PGK1 mRNA level. However, we believe that this is likely 
an artifact of transfer or hybridization, as the increase is not obvious at other time points 
and the corresponding protein level does not change. Together these observations suggest 
that the presence of Smy2 and Syh1 impact the transcript abundance of a subset of 
mRNAs, including TDA1, but not all cellular mRNAs.  
 
3.13 Increased TDA1 mRNA stability in the smy2∆ syh1∆ mutant. 
    To determine if the increased TDA1 mRNA abundance in the smy2 syh1 double 
knockout mutant is due to increased RNA stability, I performed the mRNA half-life (T1/2) 
assay on TDA1 and PGK1 transcripts as described in Coller, 2008. Transcription of the 
tested gene fused to the GAL1 promoter was activated by maintaining logarithmic growth 
in galactose medium, and then shut off by glucose addition. The samples were harvested 
at the indicated time points after glucose repression, and subjected to northern analysis. 
The image of rRNA (not shown) bands demonstrates equal sample loading (data not 
shown). In smy2∆ syh1∆ low density cultures grown at 25°C, the TDA1 mRNA has an 
average T1/2 of 4.73 minutes (SD=0.35), compared to 3.33 minutes (SD=0.15) in wild-
type cells (Figure 3.15A). This difference is statistically significant based on a p-value of 
0.014 by paired t-test statistics. In contrast, PGK1 mRNA has an average T1/2 of 29.5 
minutes (SD=0.88) in wild-type cells and 25.2 minutes (SD=0.65) in smy2∆ syh1∆ cells 
(Figure 3.15B). However, the difference is subtle here as indicated by the nearly 
overlapping PGK1 decay curves between wild type and the smy2∆ syh1∆ cells, 
suggesting little or no effects of Smy2 and Syh1 on PGK1 mRNA stability. Therefore, we 
conclude that the more efficient accumulation of GAL1-expressed TDA1 mRNA and 
protein in the smy2∆ syh1∆ mutant is due, at least in part, to less efficient mRNA decay. 
And, unlike the results presented for RPS17A pre-mRNA, TDA1 mRNA stabilization 
does not require high culture density.  
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Figure 3.14. Increased TDA1, but not PGK1, mRNA and protein abundance in the 
smy2 syh1 null mutant. Yeast containing SMY2 or/and SYH1 or none were transformed 
with pGAL1-TDA1 (A) or pGAL1-PGK1 (B). The transformants were cultivated in 
glucose media lacking of uracil overnight, and shifted to galactose media for the 
indicated time points (0h, 6h, 12h and 24h). For each culture at the specified time points, 
a portion of the master culture was harvested and stored in two aliquots. One aliquot was 
used for northern blot analysis (left panel), and the other for western blot analysis (right 
panel). For mRNA analysis, the mRNA abundance was normalized with SCR1 mRNA 
signal, and the relative transcript abundance (with standard deviation presented if 
applicable) represents the fold changes comparing to the relative abundance in the wild-
type background. For protein analysis, the same comparison was performed except that 
Rpl3 protein was used as the normalization control. 
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B.  
 
 
Figure 3.15. Half-life measurements of the TDA1 and PGK1 mRNAs. Wild type or 
smy2syh1 null cells with pGAL1-TDA1 (A) or pGAL1-PGK1 (B) were cultivated 
continuously in galactose medium lacking uracil for 24h, and shifted to the corresponding 
glucose medium for transcriptional shutoff. The time points at which cells were harvest 
after glucose repression are marked on the top. Total RNA was prepared and subjected to 
northern analysis using TDA1- or PGK1- specific probes. The average half-life span with 
standard deviations was presented on the right. The data from two independent 
experiments of (A) and (B) were averaged and plotted on a logarithmic scale, with the 
standard deviation marked.  
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3.14 The BBP-binding site present on TDA1 mRNA is not required for transcript 
stabilization in the smy2∆ syh1∆ mutant background. 
     The presence of the UACUAAC motif in the TDA1 transcript and the reported 
interaction of the BBP protein with both TDA1 mRNA (Hogan et al., 2010) and with the 
Smy2 and Syh1 P-body proteins (Georgiev et al, 2007) led me to speculate that TDA1 
mRNA may be targeted for enhanced turnover by Smy2 and Syh1 through BBP  
association. To investigate this issue, point mutations, previously shown to abolish BBP 
association with mRNA in vitro (Berglund et al., 1997), were introduced into the TDA1 
TACTAAC motif on the pGAL1-TDA1 construct. We then compared the wild-type and 
mutated constructs for changes in TDA1 mRNA and protein abundance in the presence 
and absence of SMY2 and SYH1 genes. The first mutant carries three silent mutations in 
the hepta-nucleotide BBP binding site, leaving the Tda1-1 protein coding potential 
unchanged (tda1-1: G ACA AAT, with point mutations underlined) (Figure 3.16A). The 
second mutated version carries two additional point mutations in addition to the tda1-1 
substitutions, thus changing 5 of the 7 consensus nucleotides (tda1-2: G ACA GCT, with 
point mutations underlined) into a fully scrambled sequence. The tda1-2 lesion also 
results in a single amino acid substitution [N559A] (Figure 3.16A).  
    The analysis of tda1-1 and tda1-2 mRNA levels after a 12-hour galactose induction 
shows a pattern similar with what is seen with the wild-type TDA1. For both the tda1-1 
and tda1-2 transcripts, their abundance is not affected in either of the single mutants. In 
the smy2Δ syh1Δ mutant, the tda1-1 and tda1-2 transcripts show a 1.4- and 2.4 fold 
increase, respectively, compared to the control (Figure 3.16B). However, more efforts are 
need to confirm these results. The parallel protein measurement reveals a pattern similar 
with the wild-type Tda1, which is elevated average protein abundance in the smy2Δ and 
smy2Δ syh1Δ mutants after 6-hour and 12-hour galactose induction (Figure 3.16C). 
However, the difference is not statistically significant due to variations between 
experiments. Nevertheless, the trend indicates that the tda1 point mutations do not block 
(and may have little impact upon) the effects of Smy2 and Syh1 on Tda1 mRNA and 
protein abundance.  
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Figure 3.16. Smy2 and Syh1’s impact on mRNA/protein abundance does not require 
the presence of branchpoint motif. Point mutations demonstrated (A) were introduced 
into the wild-type pGAL1-TDA1 construct. The derived pGAL1-tda1-1 and pGAL1-tda1-
2 (B-C), along with pGAL1-DJP1/RPI1/STE7 (D), were transformed respectively into 
cells with the presence (+) and absence (-) of both SMY2 and SYH1. The transformants 
were cultivated in glucose media lacking uracil overnight, and shifted to galactose media 
for the indicated time points. For mRNA analysis, the mRNA abundance was normalized 
with SCR1 mRNA signal, and the relative transcript abundance (with standard deviation 
presented if applicable) represents the fold changes comparing to the relative abundance 
in the wild-type background. For protein analysis, the same comparison was performed 
except that Rpl3 protein was used as the normalization control. 
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     In addition to TDA1, I tested two other mRNAs (RPI1 and DJP1), which have a 
UACUAAC sequence and co-purify with BBP, for Smy2 and Syh1 sensitivity. A 
randomly selected gene STE7, which encodes the signal transducing MAP kinase kinase, 
without a BBP binding site and which does not co-purify with BBP (Hogan et al., 2010), 
was included as a control. As presented in Figure 3.16D, no obvious genotype-specific 
differences were seen for mRNA or protein abundance, showing that not all transcripts 
with the UACUAAC BBP-binding motif are responsive to Smy2 and Syh1 levels. Based 
on the above observations, it suggests that the presence of a BBP binding motif is not 
sufficient or necessary for transcript sensitivity to Smy2 and Syh1.  
 
3.15 Tda1 abundance is not changed by removal of the Smy2 binding domain of 
BBP.  
 Here, I tested whether BBP association with Smy2 and Syh1 impacts Tda1 protein 
abundance. The wild-type TDA1 construct (pGAL1-TDA1) or the mutants (pGAL1-tda1-1 
or pGAL1-tda1-2) was transformed into the yeast carrying a wild-type BBP gene or the 
bbp∆C allele described above. The yeast cultures were induced with galactose, and 
subsequently harvested for protein analysis. In glucose medium, no detectable protein 
from the GAL1 constructs was observed (data not shown). After 6-hour and 12-hour 
galactose induction, as expected, wild-type Tda1 protein was easily detectable but not 
clearly distinguishable between the BBP and bbp∆C backgrounds (Figure 3.17, first two 
lanes). The parallel analysis of mutant Tda1 protein abundance also revealed no obvious 
change of protein expression in the BBP and bbp∆C mutants (Figure 3.17, last four lanes). 
Therefore, we conclude that the proline-rich domain within BBP and the best fit BBP-
binding site within TDA1 are likely not critical for regulating Tda1 protein abundance via 
Smy2 and Syh1.  
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Figure 3.17. The loss of BBP C-terminal has no obvious effects on Tda1 protein 
abundance. The pGAL1-TDA1, or its derivative pGAL1-tda1-1 and pGAL1-tda1-2, were 
transformed separately into the wild-type BBP or the BBP C-terminal deletion mutant 
(bbp∆C), and assayed for the protein abundance expressed from the pGAL1 constructs. 
Rpl3 protein was probed as the loading control. The relative abundance of the wild-type 
or mutant Tda1 protein represents the fold changes comparing to the relative Tda1/Rpl3 
ratio in the wild-type background. 
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3.16 SMY2 and SYH1 overexpression inhibits growth.   
     No pronounced growth defects were observed with the smy2 or/and syh1 deletion 
mutants described above. I next tested the growth characteristics of yeast with increased 
levels of SMY2 or SYH1 expression. To do this, I introduced plasmid-based SMY2 and 
SYH1 genes expressed from the robust GAL1 promoter (Gelperin et al., 2005) into the 
wild-type yeast and compared colony growth with an equivalent strain bearing a matched 
empty vector control, BG1766. On glucose medium where GAL1-transcription is 
repressed, all the strains grow equivalently (Figure 3.18A left panel). In contrast, 
induction of SMY2 or SYH1 overexpression by galactose addition inhibits cell growth 
compared to what is seen with the BG1766 empty vector control (Figure 3.18A right 
panel). While overexpression of SMY2 only modestly impairs growth, enhanced 
expression of SYH1 is extremely toxic. Consistent with this plate assay, the growth curve 
analysis performed in liquid medium also shows severe growth inhibition by SYH1 
overexpression (Figure 3.18B). The culture with increased Syh1 activity showed an 
average doubling time of 7.8 hours, nearly 2 times longer than the wild-type control 
(doubling time of 4.3 hours). In contrast, in liquid culture I could not detect an obvious 
change in the growth of yeast that overexpress SMY2 in liquid medium.  
One concern with the overexpression data presented above is that the GAL1-derived 
translation products contain a C-terminal protein A -protease 3C- HA -6x His tag, which 
might contribute to the observed toxicity. To rule this possibility out, I fused a tag-free 
SYH1 ORF with the GAL1 promoter on the p425GAL1-vector (Mumberg et al., 1995). 
The promoter used in this particular construct is a truncated version of GAL1 promoter, 
missing one of the 3 UAS elements required for full galactose induction. Nevertheless, as 
shown in Figure 3.18C, overexpression of a tag-free SYH1 from the p425GAL1-SYH1 
construct still leads to severe growth impairment, confirming that the growth inhibition 
results directly from SYH1 overexpression.  
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A.  
 
 
 
 
 
 
 
B.   
 
 
 
 
 
 
 
 
C. 
 
 
 
Figure 3.18. SMY2 and SYH1 overexpression leads to growth inhibition. (A) The 
pGAL1-empty (BG1766 plasmid), pGAL1-SMY2 and pGAL1-SYH1 constructs were 
introduced into the wild-type (BY4742) strain respectively. The cultures were spotted at 
10-fold serial dilutions on CSM –ura plates with either glucose or galactose, and scored 
for their growth at 25°C. (B) Yeast carrying the indicated plasmids were cultivated in the 
galactose medium and measured for readings of OD600 every 6 hour till the cultures 
reached the stationary phase. The ODs against the time were presented in a semi-log 
scale plot. (C) The growth of wild type (BY4742) strains with p425GALL-empty or 
p425GALL-SYH1 on CSM –ura plates with either glucose or galactose as the sole carbon 
source at 25°C. 
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3.17 Increased BBP copy number partially rescues the SYH1 high-dosage toxicity in 
a splicing-independent manner.  
    We next investigated the toxicity associated with SMY2 or SYH1 overexpression. We 
argued that the observed Smy2 or Syh1-induced growth inhibition may be due to the 
sequestration of certain interacting proteins in non-functional complexes. If this is the 
case, co-overexpression of the interacting factors could potentially relieve the growth 
defects through titration of Smy2 or Syh1. Consistent with our speculation, 
transformation of a BBP-bearing high-copy plasmid (YepLac181-BBP) into yeast 
partially suppresses the growth inhibition observed by SYH1 overexpression (Figure 
3.19A). Curiously, co-overexpression of BBP does not improve the modest growth 
impairment seen with SMY2 overexpression (data not shown). One possible explanation 
for the SYH1 induced growth inhibition with overexpression is that high Syh1 levels 
sequesters BBP away from the splicing apparatus, and increased BBP dosage buffers this 
sequestration. Alternatively, it is possible that excess Syh1 sequesters other protein(s) 
with the GYF binding motif leading to growth inhibition (but not necessarily splicing 
inhibition), and that increased BBP relieves this complication through competitive 
binding. To investigate these possibilities, northern analysis was conducted to estimate 
the splicing efficiency with and without SYH1 overexpression. As the general splicing is 
still robust when SYH1 is overexpressed (Figure 3.19B), it seems unlikely that BBP (or 
Prp8) sequestration is the primary cause of SYH1-induced growth inhibition. 
In an attempt to identify possible targets for Syh1 sequestration, I co-transformed 
genomic libraries constructed in the 2µ high-copy YEP13 vector (Nasmyth and Tatchell, 
1980) into the wild-type strain with the pGAL1- SYH1 plasmid and screened for 
transformants with improved growth on galactose medium. Unfortunately, no dosage 
suppressor clones were found in the ~10,000 colonies I screened. Given the 12.5mbp 
yeast genome and a genomic insert size of approximately 10,000bp with 100% of 
plasmids containing an insert, this provided roughly 8-fold coverage of the genome. It is 
clear, however, that the coverage was not as complete as expected since, in the very least, 
BBP-containing clones should have been found.  
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Figure 3.19. The growth inhibition from SYH1 over-expression is not due to 
impaired splicing, although it is partially relieved by increased BBP dosage. (A) The 
growth of yeast with indicated constructs on CSM –ura –leu medium with either glucose 
or galactose as the sole carbon source at 25°C. (B) Northern analysis of RNA isolated 
from cells transformed with GAL1-driven copies of SQS1, SMY2, SYH1 and empty vector. 
Cultures were grown in glucose medium (0h) and shifted to galactose medium for 12h. 
The precursor of RPS17A (P) and spliced product (M) were marked.  
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As an alternative way to identify SYH1-interacting genes, I used a candidate gene 
approach. To do this, I co-transformed yeast with the p425GAL1-SYH1 gene and a set of 
a similar GAL1 fusion genes previously described to show genetic or physical 
interactions with SYH1 (Georgiev et al., 2007; Ito et al., 2001; Kofler et al., 2005). 
Overexpression of several of these genes in the absence of pGAL1-SYH1, including EAP1, 
DHH1, PRP8, CCR4 and ENT1, led to growth inhibition (Figure 3.20 right panel), 
making it difficult to interpret the co-expression results (Figure 3.20 left panel). 
Overexpression of others (i.e., YPT6, STE7, VPS64, TIF34) caused no or slight growth 
defects in the absence of pGAL1-SYH1. Co-overexpression of SYH1 with YPT6, STE7 
and TIF34 leads to more severe growth inhibition than seen with SYH1 alone (Figure 
3.20), suggesting negative genetic interactions occur with this gene set. A single gene, 
VPS64, shows modestly improved growth when co-expressed with SYH1. VPS64 was 
originally identified in a screen for mutants defective in cytoplasm to vacuolar protein 
sorting (Bonangelino et al., 2002), a biological phenomenon potentially relevant to Syh1 
function (Georgiev et al., 2008). In addition to the set presented above, I also scored two 
general translation factors Tif34 (YepLac181-TIF34) and Tif35 (YepLac181-TIF35), both 
reported to interact with Syh1by yeast two-hybrid (Ito et al., 2001), for changes in growth 
when co-expressed with SYH1. In this case, the co-transformed genes were expressed 
from the high-copy plasmid, YEplac181 vector, rather than from the GAL1 promoter. The 
results showed that co-expression of TIF34 and TIF35 does not relieve SYH1 toxicity 
(data not shown).  
 
3.18 SYH1 toxicity does not result from impaired general translation. 
     In addition to splicing factors BBP and Prp8, Smy2 or/and Syh1 physically or 
genetically interact with several proteins involved in translation, including Nip1, Eap1, 
Tif34 and Tif35 (Sezen et al., 2009; Ito et al., 2001). It is conceivable, therefore, that the 
toxicity observed with increased SYH1 expression might result from impaired protein 
translation. To investigate this, I used a metabolic labeling approach (Belk et al. 1999) to 
measure overall translational efficiency with and without SYH1 overexpression. Figure 
3.21A shows that throughout the 8-hour galactose induction period yeast that express 
either the BG1766 empty vector or the pGAL1-SYH1 construct had comparable protein 
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synthesis capacity, as monitored by the 35S-labeled amino acid incorporation into TCA 
precipitable proteins. The incorporation capacity peaks after 2-hour galactose induction, 
which might be due to the adaption of yeast cells to the fresh medium. I also repeated this 
experiment and monitored full-length protein production by gel electrophoresis. As 
presented in Figure 3.21B, yeast transformed with the BG1766 empty vector control or 
the pGAL1-SYH1 plasmid show similar pattern of 35S-incorporation into newly 
synthesized protein (bottom panel) over the 24-hour induction period. Based on these 
observations, it appears that the growth inhibition associated with enhanced SYH1 
expression is not due to impaired general translation capacity.  
    It certainly remains possible that while the bulk translation continues unimpeded, 
select mRNAs are poorly translated with SYH1 overexpression. Since TDA1 mRNA was 
identified as sensitive to Smy2 and Syh1 levels, I measured Tda1 protein abundance with 
and without SYH1 overexpression (Figure 3.22). The western analysis shows Syh1 
accumulation by 6 hours after galactose addition with this protein reaching maximal 
levels by 12 hours.  However, the abundance of the Tda1 protein (here monitored as a 
Tap-tagged genomic integrant) does not appreciably change with SYH1 overexpression 
through at least 24 hours, by when growth inhibition is clearly evidenced (Figure 3.12B). 
Therefore, while this experiment does not test directly if TDA1 translation efficiency is 
impaired with SYH1 overexpression, it does indicate that the Syh1 toxicity is not 
correlated with major changes in Tda1 protein abundance.  
 
                                                                                            Copyright © Min Chen 2013 
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Fig
ure 3.20. Impacts of co-overexpression of SYH1-interacting genes on the inhibitory 
growth from high-dosage SYH1. Left panel: yeast with p425GALL-empty or 
p425GALL-SYH1 constructs were transformed with a second indicated GAL1-driven 
plasmid. Yeast growth were assayed on CSM –ura –leu medium with either glucose or 
galactose as the sole carbon source at 25°C. Right panel: the growth assay of yeast with 
just the GAL1-driven constructs on –ura medium with either glucose or galactose as the 
sole carbon source at 25°C. 
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Figure 3.21. 35S-incorporation in yeast cells with and without SYH1 overexpression. 
Cells harboring either pGAL1-empty or pGAL1-SYH1 constructs were subjected to 
galactose inducted for the indicated length of time, and harvested for 35S-incorporation 
measurements. (A) Cells were subjected to TCA precipitation and scintillation counting. 
The average of the triplicates was plotted, with standard deviations. (B) Cells were 
subjected to protein preparation and polyacrylamide gel separation. The top panel is the 
gel image of coomassie blue staining, and the bottom is the scan image from 
phosphorimager. 
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Figure 3.22. SYH1 overexpression does not affect endogenous Tda1 protein 
abundance. TDA1 TAP-tagged yeast harboring either the pGAL1-empty or pGAL1-SYH1 
constructs were subjected to galactose inducted for the indicated length of time and 
western analysis. The induction of Syh1 overexpression was evidenced with detected 
Syh1 signals. Rpl3 protein was probed as the loading control. The relative abundance of 
Tda1 represents the fold changes comparing to the relative Tda1/Rpl3 ratio in the wild-
type background at each time point. 
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Chapter 4 Discussion 
    In this study, I addressed the question of whether the proposed non-splicing role for the 
site-specific RNA binding protein, BBP, might relate to a cytoplasmic function linked to 
its protein binding partners, Smy2 and Syh1. Consistent with this hypothesis, we show 
that the presence of Smy2 and Syh1 alter the intracellular levels of certain naturally 
occurring yeast RNA, including at least three different transcripts that co-purify with the 
BBP protein. Furthermore, we demonstrate that the increase in RNA abundance which 
occurs in the smy2Δ syh1Δ background results from RNA stabilization rather than 
increased gene expression, establishing a role for this protein pair in RNA turnover.  The 
greatest effect was observed when the SMY2 and SYH1 genes were simultaneously 
deleted, suggesting a level of functional redundancy consistent with the structural 
similarities of the two proteins (Figure 1.3). We establish a new genetic link between 
Syh1 and BBP by demonstrating that the cytotoxic effects of SYH1 overexpression can be 
partially relieved by simultaneously enhanced BBP expression. Consistent with a non-
splicing function, Syh1 toxicity is not correlated with impaired RNA processing. 
Surprisingly, my data suggest that BBP-RNA interaction is not required for the proposed 
mechanism of Smy2 and Syh1-sensitive RNA turnover.  Below I present a discussion of 
the characteristics of the Smy2/ Syh1 sensitive RNAs and speculate on how these 
proteins might act to promote RNA turnover in light of our observations and previously 
reported genetic and biochemical factors contributing to RNA decay.     
 
4.1 Brief overview of cytoplasmic RNA decay  
     All RNA species in eukaryotic cells are subject to post-transcriptional regulations. 
Newly transcribed pre-mRNA generally enters the RNA processing cycle to become 
functional. Aberrant or unprocessed nuclear RNA could be retained in the nucleus or 
exported into cytoplasm for degradation, preventing the production of defective mRNA. 
The nuclear RNA decay is largely performed by the nuclear exosome (Sloan et al., 2012), 
along with its cofactor, the TRAMP (TRF–AIR–MTR4 polyadenylation) complex 
(LaCava et al., 2005). The dsRNA-specific ribonuclease, Rnt1, cleaves the stem-loop 
structure within introns, and the resulting products are then degraded by the nuclear 
exosome components (Danin-Kreiselman et al., 2003). Cytoplasmic RNAs are turned 
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over through conserved eukaryotic RNA degradation pathways, which is generally 
initiated by the shortening of the 3’ poly(A) tail. This process is called deadenylation, and 
is largely mediated in yeast by the Ccr4/Not/Pop2 complex, with Ccr4 as the major 
catalytic subunit (Tucker et al., 2002). Following deadenylation, mRNAs are decapped by 
the Dcp1/Dcp2 decapping enzymes and then degraded in a 5’-3’ direction by the Xrn1 
exonuclease (Kenna et al., 1993) and in the 3’-5’ direction by the cytoplasmic exosome. 
In addition to the low-level constitutive removal of functional RNAs, cytoplasmic RNA 
decay removes defective transcripts resulting from errors in RNA processing, oxidative 
damage or other environmental insults. 
    Beyond general RNA catabolism, gene-specific feedback loops are known to target 
specific RNAs for decay when found in excess over demand (Li et al., 1995; Dong et al., 
2010). In addition there are several pathways for the degradation of specific classes of 
aberrant transcripts. For instance, nonsense-mediated decay (NMD) removes mRNAs 
with premature translation termination codons (Losson and Lacroute, 1979; Parker, 2012). 
Unspliced pre-mRNAs exported into the cytoplasm are targeted by NMD since the intron 
sequences are typically non-coding and rich in nonsense codons (Sayani et al., 2008). 
NMD substrates are selected by the Upf1 protein through interaction with the translation 
termination complex, which leads to the loss of translation factors and recruitment of 
Upf2, Upf3 and the RNA decay components described above. mRNAs that stall during 
translation elongation (e.g., due to internal secondary structures) are targeted by the No-
Go decay (NGD) pathway, which leads to the endonucleolytic cleavage of mRNAs by a 
yet-to-be-defined endonuclease and subsequent degradation by Xrn1 and the cytoplasmic 
exosome (Doma and Parker, 2006). mRNAs without translation termination codons are 
also targeted for turnover, by a process called non-stop decay (NSD). It is proposed that a 
stalled ribosome at the 3’ end of such an mRNA is recognized by the cytoplasmic Ski7 
protein, which subsequently recruits the Ski2/3/8 complex and the exosome to degrade 
mRNA in a 3’ to 5’ direction (Van Hoof et al., 2002). Thus, cytoplasmic RNAs undergo 
both quantity and quality controls that impact stability within the cell. 
     To-be-degraded RNAs are often enriched in cytoplasmic stress granules or P-bodies 
(reviewed in Parker, 2012).  Functional mRNAs can also reside within such cytoplasmic 
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inclusions. While it is clear that each of these complexes contain many of the same 
proteins, the exact compositions and the degree of structural overlap have not been 
definitively determined.  For simplicity, I will refer to these collectively as P-bodies or P-
body-like complexes.  Although the method of regulation is unknown, P-body-associated 
RNAs can have several fates: prolonged storage, active decay or release back into the 
translation cycle. Since NMD and the related NGD and NSD-pathways require ongoing 
translation, RNAs degraded via these mechanisms must be released from the P-body 
complexes prior to decay.    
     Recently, the Parker group identified an additional means of RNA turnover related to 
P-bodies. They showed that a portion of RNA-enriched P-bodies or stress granules are 
targeted to the yeast vacuole for degradation (Buchan et al., 2013). The vacuole is the 
yeast equivalent of the mammalian lysosome, an organelle containing numerous 
proteases and an unknown number of nucleases that acts, for instance, in the turnover of 
proteins and protein complexes through the autophagy pathway. This pathway requires 
transport of the P-body granules to the vacuole, a process likely involving the P-body 
associated type V myosin motor protein, Myo2 (Chang et al., 2008). While individual 
RNP composition presumably dictates fate, the molecular details of how RNAs are sorted 
for P-body storage, degradation, release or autophagy are unknown.  Here we propose 
that the Myo2 interacting proteins, Smy2 and Syh1 may be relevant to this sorting 
process (see below).   
4.2 Pre-mRNA accumulation under high cell density conditions and genetic 
interactions between SMY2, SYH1.  
     Under optimal growth conditions, most yeast pre-mRNA enters the splicing cycle 
while a small portion of unprocessed pre-mRNA escapes into cytoplasm where it is 
degraded by NMD (Sayani et al., 2008). Under certain stress conditions (e.g., amino acid 
starvation or ethanol addition), splicing appears to become impaired and the proportion of 
unprocessed RNAs increases (Pleiss et al., 2007a). The proposed splicing inhibition is 
transcript-specific, however, as not all pre-mRNAs are affected and different subsets of 
RNAs are impacted by the amino acid starvation and ethanol sensitivity pathways. We 
find that the RPS17A and RPS29B, but not RPS22B or RPL7A pre-mRNAs accumulate in 
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high-density cultures even in the absence of specific inhibitors of amino acid biosynthesis 
or other stressors. A priori, enhanced pre-mRNA accumulation might result from splicing 
inhibition, pre-mRNA stabilization or a combination of both events. If splicing is affected, 
then the fact that not all intron-containing genes are impacted equivalently is not 
unexpected, since earlier studies have shown differential transcript sensitivity even when 
core components of the spliceosome are mutated (Clark et al., 2002; Pleiss et al., 2007b). 
The unprocessed pre-mRNAs from different genes appear to show differential sensitivity 
to degradation after splicing inhibition, with RNAs bearing suboptimal splicing signals 
being especially sensitive to NMD decay (Sayani et al., 2008).  Each of the RNAs 
assayed in this present study has consensus splice sites, therefore this cannot be the basis 
for the differential response of RPS17A and RPS29B, vs RPS22B or RPL7A to smy2Δ 
syh1Δ. 
     As stated above, the greater accumulation of RPS17A and RPS29B pre-mRNAs 
compared with the RPS22B and RPL7A pre-mRNAs might be due to intrinsically less 
efficient processing of certain pre-mRNAs by the splicing or turnover pathways.  That is, 
all intron-bearing RNAs may be sensitive to Smy2/Syh1 removal but that more efficient 
pre-mRNA splicing or greater sensitivity to other RNA decay pathways acting in parallel 
may mask this sensitivity for some transcripts (i.e., the pre-mRNAs that do not 
accumulate in the smy2Δ syh1Δ background). In principle, inhibiting splicing by substrate 
level mutation might be expected to promote Smy2/Syh1 sensitivity even at low cell 
density as previous work indicates that at least a portion of this mutated unspliced pre-
mRNA is likely exported to the cytoplasm where Smy2, Syh1 are predicted to operate 
(Legrain and Rosbash, 1989).  However, we find that while RPS17A-lacZ reporter pre-
mRNAs mutated at the 5’ splice site or branchpoint sequences accumulate excess pre-
mRNA there was no obvious difference between cultures of wild-type yeast or yeast 
deleted of Smy2/Syh1 at low cell density. At high cell density, however, the GUAUAU 5’ 
splice site mutant reporter responds just like the endogenous gene and super-accumulates 
pre-mRNA in the smy2Δ syh1Δ background. This increased RNA accumulation can be 
accounted for by the observed 1.5-fold increase in pre-mRNA stability under these 
conditions (Fig. 3.7). The generation times of the mutant and wild-type cultures are 
essentially identical and do not contribute substantively to this pre-mRNA half-life 
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difference.  The concordance of the endogenous RPS17A gene and RPS17A-lacZ reporter 
response reinforces the growth state dependence on pre-mRNA gains access (or responds) 
to Sym2/Syh1-dependent turnover pathway and exclude the possibility that pre-mRNA 
responsive signals exist in the 3’ half of RPS17A (which is missing in the RPS17A-lacZ 
construct (Teem and Rosbash, 1983).   
     In scanning for other features that might impact RNA stability, I noticed that the 
smy2Δ syh1Δ insensitive RPS22B and RPL7A pre-mRNAs were reported previously to 
contain dsRNA stem-loop structures in the intronic region recognized by the nuclear 
RNase III-like double-stranded endonuclease, Rnt1, substrates (Danin-Kreiselman et al., 
2003; Ghazal et al., 2005). Rnt1 is a key processing factor in the biogenesis of small 
nucleolar RNAs (snoRNAs), and its cleavage on unspliced or partially spliced precursors 
triggers RNA degradation (Chanfreau et al., 1998; Danin-Kreiselman et al., 2003). The 
presence of Rnt1 recognition signals within RPS17A and RPS29B introns has not been 
reported yet, and the analysis of secondary structures of these introns using the mfold 
software (Zuker, 2003) does not reveal any obvious Rnt1 signals according to the 
published standards (Chanfreau et al., 2000). Therefore, it is possible that RPS17A and 
RPS29B pre-mRNAs are intrinsically more stable and therefore accumulate to greater 
levels in the absence of Smy2 and Syh1 activities. Rnt1 is a nuclear activity, however, so 
in order for Smy2 and Syh1 to have an effect (assuming that this is direct), at least a 
portion of this increased pre-mRNA pool must be exported to the cytoplasm.  
4.3 Other Smy2/Syh1 sensitive transcripts 
     In addition to the intron-bearing transcripts, we looked at several other cellular 
mRNAs for changes in abundance in response to the removal of Smy2 and or Syh1. 
Admittedly, this was a biased group and focused on RNAs with one or more copies of the 
BBP binding site where the RNAs were shown to co-purify with BBP (Hogan et al., 
2008). For the GAL1-derived RPI1 and DJP1 mRNAs we saw no difference in mRNA 
abundance whether or not Smy2 or Syh1 was present.  Thus, similar to intron-bearing 
RNAs, the mere presence of the UACUUAC sequence is not sufficient to make these 
mRNAs Smy2, Syh1 sensitive. Two RNAs, the intronless TDA1 mRNA and the yeast 
Ty1 RNA did respond to these deletions, however. In both cases, the change in RNA 
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abundance was similar to that seen with RPS17A and RPS29B pre-mRNAs, specifically, 
that RNA increased in the smy2Δ syh1Δ mutant background. As TDA1 and Ty1 RNA 
accumulation did not require growth at high cell density, this growth state may influence 
the accessibility of unspliced pre-mRNA but cannot be an obligate feature for regulation 
by Smy2/Syh1. 
      TDA1 expression is tightly linked to growth state and the abundance of this transcript 
drops precipitously when yeast are cultured to high density or placed in nutritionally 
restricted medium. Super-accumulation of TDA1 mRNA in the smy2Δ syh1Δ background 
could be observed only when this genes natural transcriptional regulatory sequence was 
replaced by the galactose-inducible GAL1 promoter.  It is possible that, similar to other 
mRNAs (Kolesnikova et al., 2013; Martínez et al., 2013), excess TDA1 mRNA is 
naturally regulated through undefined post-transcriptional pathways, with Smy2 and 
Syh1 facilitating the removal of excess transcript. While the chemical half-life of TDA1 
mRNA is extended in the smy2Δ syh1Δ background, mutations of the TDA1 UACUUAC 
sequence did not appear to prevent RNA accumulation. The scrambled UACUUAC 
sequences of the tda1-1 and tda1-2 mutants look no more like BBP binding sites than 
other regions of the mRNA and, in vitro, such changes would fully block BBP interaction 
(Berglund et al., 1997). Although formally possible that BBP continues to interact with 
TDA1 mRNA, this seems unlikely given the high degree of sequence specificity shown 
with this site-specific RNA binding protein (Berglund et al., 1997). While I cannot 
exclude the possibility that BBP contributes in targeting RNAs to a Smy2/Syh1-sensitive 
turnover pathway, the data strongly suggest that BBP-RNA interaction is not required for 
Smy2/Syh1 sensitivity under all conditions or for all transcripts.  
    Finally, while Ty1 retrotransposon RNAs are highly transcribed in budding yeast, 
retrotransposition is negatively regulated to maintain genome stability (Nyswaner et al., 
2008). Our results reveal that Smy2 and Syh1 have a redundant role in repressing Ty1 
retrotransposition by limiting Ty1 transcript abundance, with Syh1 showing a dominant 
role. As stated above, Smy2 and Syh1 localize to P-bodies.  P-bodies or structures of 
related composition have a unique and unexpected role in Ty1 biogenesis as cDNA 
synthesis and viral-like particle (VLP) production is enhanced by passage through these 
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structures (Dutko et al. 2010). Unlike the smy2 syh1 deletions which increase 
transposition frequency, mutations in multiple P-body components (e.g., (Xrn1, Dhh1, 
Lsm1, Pat1) reduce retrotransposition, arguably by interfering with P-body assembly or 
function (Checkley et al., 2010; Dutko et al., 2010). The basis for this difference is 
unknown although it is clear that Smy2 and Syh1 themselves not required for P-body 
biogenesis (Georgiev et al, 2007).  While we have not rigorously ruled out transcriptional 
repression by Smy2 or Syh1 this appears unlikely as the proteins seem to be exclusively 
cytoplasmic and no published studies implicate either protein in chromatin function. 
Rather, we proposed that similar to the RPS17A pre-mRNA and TDA1 mRNAs, the loss 
of Smy2 and Syh1 stabilizes Ty1 mRNA and this added RNA results in increased Ty1 
particle assembly and retrotransposition. 
4.4 Is the proposed RNA-BBP-Syh1/Smy2 interaction biologically relevant?  
     BBP is the sole yeast representative of a class of proteins called STAR (Single 
Transduction and Activation of RNA) proteins whose members typically bind RNA co-
transcriptionally and retain association through multiple stages of RNA biogenesis, 
function and decay.  Yeast BBP binds RNA co-transcriptionally (Görnemann et al., 2005) 
and is needed for the proper retention of pre-mRNA in the nucleus (Rutz and Seraphin, 
2000), but a more active role in RNA transport or cytoplasmic function has not been 
identified.  Its binding partner, Mud2 (homology of mammalian U2AF65), does have a 
cytoplasmic phase (Huh et al., 2003), however. This observation and the fact that BBP 
and Mud2 appear to co-purify nearly quantitatively with one another (Wang et al., 2008), 
suggests the possibility that the BBP-Mud2 heterodimer serves a cytoplasmic function.   
     Smy2 and Syh1 are cytoplasmic proteins implicated in translational regulation and 
RNA turnover.  These proteins bind BBP in in vitro assays (Kofler et al., 2005; Georgiev 
et al., 2007), and at least Smy2 co-purifies with BBP from yeast extracts (Ash et al., 
2010). Our earlier work showed that a mud2 smy2 double deletion mutant has 
significantly increased translation of a reporter transcript that requires intron retention for 
translation (Wang et al., 2008).  The enhanced translation is not due to decreased splicing 
(and corresponding export of greater amounts of pre-mRNA) since there is no decrease in 
the abundance of the spliced gene product. Rather, we suggested that this may be due to 
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reduced turnover of pre-mRNA exported to the cytoplasm when Smy2 is absent. The 
results presented here support the hypothesis that a Smy2/Syh1-dependent pathway exists 
for the turnover of unspliced pre-mRNA. The data do not support Mud2-BBP-RNA 
interaction being critical in this pathway since mutation of the BBP binding site on TDA1 
mRNA did not block Smy2/Syh1 sensitivity. Also, removal of the proline-rich GYF 
binding domain of BBP by deletion of the nonessential carboxyl terminus of BBP blocks 
Smy2 association but not the RNA-stabilizing effects seen with smy2Δ syh1Δ deletion 
(Fig. 3.16-17). Syh1 also interacts with BBP through this domain.  However, recent work 
in our lab shows that that the bbpΔC encoded protein continues to bind Syh1 well in the 
Y2H assay (Rymond and Montgomery, unpublished) indicating that a second site of Syh1 
interaction exists within BBP. This observation precludes us from making a strong 
statement about Syh1-BBP interaction on the proposed RNA turnover pathway but may 
help explain why the greater toxicity of Syh1 over-expression and the fact that Syh1 
toxicity but not that of Smy2 can be partially relieved by simultaneously enhanced BBP 
expression.  In any case, a firm requirement for BBP to bind mRNA to promote the 
Smy2/Syh1 turnover pathway appears unlikely. 
     If BBP association with RNA is not an obligate prerequisite, what makes a particular 
mRNA sensitive to the presence of Smy2 and Syh1? One possibility is that Smy2 and 
Syh1 may gain access to RNA substrates through multiple different RNA-binding 
proteins. It is documented that Smy2 interacts genetically or physically with many factors 
belonging to this category, at least some of which can be found within P-body like 
complexes (Table 4.1).  For instance, these interact with the large and conserved Prp8 
(Smy2), Brr2 and Prp4 (Syh1) splicing factors, multiple broad-specificity RNA binding 
proteins involved in intracellular RNA transport such as Hek1 (Smy2), Nab2 (Smy2) and 
Npl2 (Smy2) as well as proteins involved in translational regulation (Table 4.2) and RNA 
turnover (Table 4.3).  Conceivably, redundant associations with these other RNA binding 
proteins might be sufficient to compensate for the loss of BBP-based association.   
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4.5 Smy2, Syh1 and the TOR pathway 
     I found that the accumulation of yeast pre-mRNA in the absence of Smy2 and Syh1 
was most obvious when cultures reached OD600 of approximately 3.0.  This growth state 
is associated with the diauxic shift (Russell et al., 1993), a condition that occurs when the 
nutrients become limiting and the yeast switch from anaerobic fermentation to aerobic 
respiration (DeRisi et al., 1997). During the diauxic shift, yeast reduce Tor signaling 
which promotes major changes in gene expression including transcriptional repression of 
the ribosomal RNA and ribosomal protein genes (DeRisi et al., 1997; Gash et al., 2000; 
Causton et al., 2001). The TORC1 pathway acts via its two main effector branches, the 
Sch9 kinase and the PP2A or PP2A-related protein phosphatases and regulates various 
growth-related processes (Figure 4.1). The decreased colony growth of the Tor1 and Tor2 
double mutant in the smy2Δ syh1Δ background shows that Smy2 and Syh1 are required 
for efficient growth when this nutrient sensing pathway is inhibited and suggests some 
level of functional overlap with this major signaling pathway.   
      Previous studies have shown that inhibition of the TORC1 complex reduces the level 
of both pre-mRNA and spliced mRNA from ribosomal protein genes due to 
transcriptional repression (Bergkessel et al., 2011). Taking this further, we see no 
evidence that diminished TOR signaling enhances pre-mRNA accumulation in the smy2Δ 
syh1Δ quadruple mutant or after TORC1 inhibition by rapamycin.  If not through changes 
in ribosomal RNA processing or stability, how might the removal of Smy2 and Syh1 
exacerbate diminished TOR signaling?  One possibility is that the slow growth may result 
from impaired protein synthesis as the loss TORC1 function blocks phosphorylation of 
the cap binding factor, Cdc33 (yeast eIF4E), needed for efficient translation of most 
mRNAs  (Barbet et al., 1996). Smy2 co-purifies with Cdc33 and the Cdc33-associated 
protein Eap1 (Sezen et al., 2009; Cosentino et al., 2000). While Cdc33 has a positive role 
in promoting translation, Eap1 acts as a translational inhibitor by competing with eIF4G 
for eIF4E binding and stimulating mRNA turnover (Blewett and Goldstrohm, 2012).  The 
eap1 deletion renders yeast rapamycin insensitive indicating that Eap1 is intimately 
involved in the TORC1 cascade (Cosentino et al., 2000).  It is possible, although far from 
certain, that the loss of Smy2 -Cdc33 association in the smy2Δ syh1Δ background  
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Table 4.1. A list of RNA-associated proteins that interact with Smy2/ Syh1 in 
addition to BBP and Prp8 
 
 
 
 
Genes Interaction Experiment Functions References 
BFR1          
SMY2 
Synthetic 
lethality 
Components of mRNP 
complexes associated 
with polyribosomes 
Sezen et 
al., 2009 
BRR2 
SYH1 
Two hybrid 
RNA-dependent 
ATPase RNA helicase; 
required for U4/U6 
disruption during 
spliceosome activation 
Van Nues and 
Beggs, 2001 
BRR2 
SMY2 
Affinity 
capture 
RNA-dependent 
ATPase RNA helicase; 
required for U4/U6 
disruption during 
spliceosome activation Ash et al., 2010 
CDC33 
SMY2 
Affinity 
capture 
mRNA cap binding 
protein and translation 
initiation factor eIF4E Sezen et al., 2009 
HEK2 
SMY2 
Affinity 
capture 
RNA binding protein 
involved in asymmetric 
localization of ASH1 
mRNA 
Hasegawa et al, 
2008 
NAB2 
SMY2 
Affinity 
capture 
Nuclear 
polyadenylated RNA-
binding protein; 
required for nuclear 
mRNA export Batisse et al., 2009 
NPL3 
SMY2 
Affinity 
capture 
RNA-binding protein 
shuttles between 
nucleus and cytoplasm; 
involved in 
transcription, pre-
mRNA splicing and 
translation controls Ash et al., 2010 
SCP160 
SMY2 
Synthetic 
lethality 
Essential RNA-binding 
G protein effector of 
mating response 
pathway Sezen et al., 2009 
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 Table 4.2 A list of translational factors that interact with Smy2/Syh1 
 
 
 
 
 
 
 
 
 
 
 
 
Genes Interaction Experiment Functions References 
CDC33 
SMY2 
Affinity 
capture 
mRNA cap binding 
protein and translation 
initiation factor eIF4E 
Sezen et 
al., 2009 
EAP1 
SMY2 Affinity 
capture 
 
Synthetic 
lethality 
IF4E-associated 
protein, competes with 
eIF4G for binding to 
eIF4E 
Ash et al., 2010 
 
 
Sezen et al., 2009 
TIF34 
SYH1 Affinity 
capture 
 
Two Hybrid 
eIF3i subunit of the 
eukaryotic translation 
initiation factor 3 
(eIF3) 
Krogan et al., 2006 
 
 
Ito et al., 2001 
TIF35 
SYH1 
Two Hybrid 
eIF3g subunit of the 
eukaryotic translation 
initiation factor 3 
(eIF3) Ito et al., 2001 
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Table 4.3 A list of RNA decay factors that interact with Smy2/Syh1 
 
 
 
 
 
 
 
Genes Interaction Experiment Functions References 
CCR4 
SMY2 
Affinity 
capture 
Component of the 
CCR4-NOT 
transcriptional complex 
Ash et al., 
2010 
CDC39 
SMY2 
Affinity 
capture 
Component of the 
CCR4-NOT 
transcriptional complex Ash et al., 2010 
EAP1 
SMY2 Affinity 
capture 
 
Synthetic 
lethality 
IF4E-associated 
protein, competes with 
eIF4G for binding to 
eIF4E 
Ash et al., 2010 
 
 
Sezen et al., 2009 
MOT2 
SMY2 
Affinity 
capture 
Ubiquitin-protein 
ligase subunit of the 
CCR4-NOT complex 
Ash et al., 
2010 
NOT5 
SMY2 
Affinity 
capture 
Component of the 
CCR4-NOT 
transcriptional complex Ash et al., 2010 
POP2 
SMY2 
Affinity 
capture 
Ubiquitin-protein 
ligase subunit of the 
CCR4-NOT complex 
Ash et al., 
2010 
XRN1 
SMY2 
Affinity 
capture 
Evolutionarily-
conserved 5'-3' 
exonuclease Ash et al., 2010 
NMD2 
SYH1 
Negative 
genetic 
Protein involved in the 
nonsense-mediated 
mRNA decay (NMD) 
pathway Costanzo et al., 2010 
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                     (adapted from Broach, 2012; Loewith and Hall, 2011; Huber et al., 2009; Zaman et al., 2008) 
Figure 4.1. Model of TORC1 signaling in budding yeast. TORC1 activity is activated 
by rich nutrients and repressed by nutrient depletion, a variety of stress conditions or 
rapamycin exposure. Presented here is the pathway of known activators and repressors of 
Tor based signaling based on studies from Broach, 2012; Loewith and Hall, 2011; Huber 
et al., 2009; Zaman et al., 2008.  Inhibited TORC1, through both Sch9 and PP2A, also 
leads to decreased translation initiation via yeast eIF4E (Cdc33) and induction of stress 
response genes induced by dephosphorylated Msn2/Msn4 transcription factors. Genetic 
or physical interactions link Smy2 or Syh1 to translation regulation (refer to Cdc33 and 
any others that may be relevant). 
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exacerbates the effects of diminished TORC1 function by favoring the Eap1-based 
inhibition of translation and resulting in showed colony growth.   
4.6 A model for Smy2 and Syh1 activity in RNA metabolism 
     Smy2 and Syh1 were initially proposed to play roles in RNA metabolism, especially 
RNA decay, based in part on their co-localization with P-bodies under stress conditions 
and Smy2 interaction with authentic mRNA decay components (i.e., Ccr4, Not1, Not4, 
Not5, Pop2, Pat1, Xrn1/Kem1/Ski1) by peptide binding or affinity capture assays 
(Georgiev et al, 2007; Ash et al., 2010). Syh1 also interacts genetically with factors active 
in RNA turnover (Pat1, NMD2) and co-purifies interacts by the two-hybrid assay with 
proteins active in translational regulation (e.g., Tif34 and Tif35) (Ito et al., 2001). Our 
data supports the view that Smy2 and Syh1 act, at least in part, to support the turnover of 
select RNAs.   
      A speculative model for Smy2/Syh1 function in RNA turnover is presented in Figure 
4.2. Upon nutrient starvation or other stress exposures, various transcripts are known to 
be targeted to cytoplasmic P-bodies (Sheth and Parker, 2007). Unspliced pre-mRNA 
(Sayani et al., 2008), pre-mRNA splicing factors (Bucjingham and Liu, 2011) and Ty1 
RNA (Checkley et al., 2010; Dutko et al. 2010) are all known to accumulate in P-bodies 
or similar cytoplasmic inclusions with overlapping but not necessarily identical protein 
compositions (Balagopal and Parker, 2009). RNAs recruited to such cytoplasmic 
inclusions can have multiple fates including local decay, release to re-enter the 
translational cycle or Myo2-associated transport to the vacuole for decay (Thompson and 
Parker, 2009; Chang et al., 2004). We propose that Smy2 and Syh1 associate with subsets 
of RNP transcripts (e.g., pre-mRNA, Ty1 RNA, excess Tda1 RNA) within P-bodies 
through contact with BBP, Prp8 or more generic high-affinity RNA binding proteins (e.g., 
Hek1, Nab2, Npl2). In principle, the RNA binding protein-Smy2/Syh1 complex may 
directly “hand off” the RNAs to the turnover factors or, alternatively direct delivery of 
the RNAs to alternate sites of decay. We propose that the Smy2/Syh1-associated Myo2 
myosin acts in this manner to transport P-body complexes to the vacuole for decay.  At 
least a portion of the mRNA expressed from a large fraction of yeast genes (50%) can be 
recovered in cytoplasmic complexes transported by cytoplasmic myosin motors (Chang 
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et al., 2004). Conceivably, these represent RNAs destined to decay by this turnover 
pathway due to damage or regulation to maintain appropriate transcript abundance.     
     We speculate that vacuole-associated decay pathway works in parallel with processes 
that degrade RNA within the P-body or release the RNA from the P-body for recruitment 
by the ribosome. Parallel pathways would explain the additive nature on RNA levels 
when both NMD is inhibited and SMY2 and SYH1 are deleted. Also, as autophagy is 
enhanced under nutrient limitation, one anticipates that this leg of the pathway might be 
more relevant at high cell density – consistent with the greater accumulation of pre-
mRNA after the diauxic shift. What drives RNA fate once P-body associated towards 
storage, local decay, vacuole deliver or release is unknown but presumably relates to the 
specifics of local RNP structure and P-body heterogeneity. 
    While Ty1 reverse transcription and VLP assembly specifically occurs within P-body-
like particles, we propose that a portion of this Ty1 RNA is not productive in cDNA 
synthesis but is lost through this vacuole-based decay system of P-body removal. While 
loss of Smy2 and Syh1 increases Ty1 mRNA levels inactivation of NMD by loss of Upf1 
only modestly increases Ty1 mRNA abundance, arguing against extensive turnover by 
NMD (note: translation of Ty1 gag-pol does involve a translational frame-shift which, in 
principle, might render this transcript sensitive to NMD). If the excess Ty1 RNA is not 
largely degraded through a ribosome-associated NMD or related pathway, the turnover 
by local (i.e., P-body) decay and vacuole delivery may be important means to guard 
against run away yeast genome mutagenesis by Ty1 mobilization.   
    This model of dedicated RNA turnover does not preclude other roles for Smy2 and 
Syh1 in yeast. The physical and genetic interactions between components of the 
translational apparatus Smy2 and Syh1 mentioned above open the possibility that this 
protein contributes to one or more of the ribosome-associated decay pathways or in 
translational control. While a role in translation is attractive, our results rule out the 
possibility that Syh1 toxicity due to overexpression results in widespread RNA 
degradation or translational inhibition. It is also possible that the interactions observed 
between Smy2 and (especially) Syh1 and the membrane trafficking components or  
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Figure 4.2. A hypothetical model of Smy2 and Syh1 in impacting cytoplasmic RNA 
fate (updated).  A single yeast cell is presented. Within the cell, BBP and Mud2 
participate in the nuclear splicing and pre-mRNA retention. The cytoplasmic fate of BBP-
bound RNAs is affected by two BBP-interacting proteins Smy2 and Syh1. Under stress 
conditions, RNAs are arrested in P-bodies for translation repression or degradation. 
RNAs present in either P-bodies or translation machinery could also be degraded by the 
Myo2-mediated vacuole digestion in response to nutrition starvation.  
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intracellular signaling factors (e.g., Arl1, Ria1, Ric1, Ypt6) reflect a role in vesicular 
transport unrelated to the RNA fate issues raised here.   
 
4.7 Future directions 
Our study identifies a role for the Smy2 and Syh1 proteins in a largely uncharacterized 
pathway of RNA metabolism. Since the impact of Smy2 and Syh1 removal on sensitive 
RNA is generally in the 1.5 to 3-fold range, this appears to be a fine tuning pathway for 
modulating the yeast transcriptome. GYF domains are present in most eukaryotic species, 
from yeast to human, and are involved in various functions in gene expression regulation 
(reviewed in Kofler and Freund, 2005). Our study raises several interesting questions for 
future study in budding yeast. For instance, what characteristics make RNA sensitive to 
Smy2, Syh1 abundance?  It will be valuable to perform a genome-wide RNA-Seq 
analysis under logarithmic growth and during the diauxic shift (i.e., high density) to 
define the subset of cellular RNAs that increase in the absence of Smy2 and/or Syh1. 
While BBP association is not a prerequisite for RNA sensitivity to these factors, it will be 
interesting to learn BBP-interacting mRNAs, mRNAs associated with Myo2 or Myo4 
complexes, or other classes of RNA-binding proteins are enriched in the Smy2, Syh1 
sensitive set. Likewise, it will be interesting to learn if the sensitive RNA possess 
common structural features that may provide a clue to why these transcripts are 
differentially sorted.   
    Growth defects have been reported when myo2 mutations are combined with the two 
regulatory subunits of casein kinase 2 (CK2: Ckb1, Ckb2) (Tong et al., 2004).  
Intriguingly, CK2 activity is also required for pre-mRNA accumulation during amino 
acid starvation induced by 3-AT (Bergkessel et al., 2011). While this pre-mRNA 
accumulation was interpreted as due to splicing inhibition (Pleiss et al., 2007), it is 
equally likely that it results from cytoplasmic pre-mRNA stabilization, possibly via the 
same Myo2-Smy2/Syh1 associated pathway proposed here. If so, we anticipate that pre-
mRNA accumulation during the diauxic shift will likewise be prevented if CK2 activity 
is lost.  Scoring double, triple and quadruple mutant combinations of the SMY2 and SYH1 
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genes and CKB1 and CKB2 genes for growth defects and changes in RNA metabolism 
may be revealing.   
      While it is known that RNA turnover by NMD does not require P-body assembly 
(Eulalio et al., 2007), it is unclear whether the proposed Sym2 Syh1-sensitive vacuole 
turnover pathway (Buchan and Parker, 2013) can function if P-body formation was 
blocked. We speculate that blocking P-body assembly, for instance, by deletion of the 
nonessential KCS1 gene (Buchan and Parker, 2013) might result in the loss of Smy2 
Syh1 sensitivity. Likewise, it will be of interest to learn if defects in the autophagy 
pathway (e.g., atg11Δ, Yorimitsu and Klionsky, 2005; Buchan and Parker, 2013) or in the 
vacuole-associate RNase function (e.g., rny1Δ, Thompson and Parker, 2009b) might 
mimic the effects of smy2 and syh1 deletions, for example, on pre-mRNA accumulation.   
 Several genes encoding P-body components are known to inhibit Ty1 transposition 
apparently by blocking formation of sites of VLP assembly (Checkley et al., 2010; Dutko 
et al. 2010).  However, stable Ty1 mRNA remains in these mutants and it would be 
interesting to compare the half-life of the residual RNA with the Ty1 RNA of wild-type 
yeast. If our model is correct, a proportion of the residual Ty1 mRNA may show an 
extended half-life even while cDNA synthesis is impaired. Finally, in Ty1 mRNA 
accumulation and other assays, simultaneous deletion SMY2 and SYH1 seems to provide 
a synergistic effect on each of our assays, we’ve attributed common activity to each. 
Going forward, it will be of great interest to more finely define the roles of each protein 
in RNA metabolism, TOR signaling, vesicular transport and perhaps other aspects of 
eukaryotic cell biology.  
                                             
                                                                                             Copyright © Min Chen 2013 
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